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Genome-wide association studies (GWAS) have been performed for many human 
complex traits, but for most of the risk loci the causal variants and the underlying molecular 
mechanisms are still unclear. Mapping quantitative trait loci (QTLs) for molecular traits, such as 
gene expression, splicing, and chromatin accessibility, connect genetic effects with gene 
regulation involved in complex traits in specific cell types. Culturing primary human neural 
progenitor cells (phNPCs) and differentiating phNPCs into neurons is an efficient way to study 
human neurodevelopment in a large number of genetically distinct individuals (Stein et al., 
2014). Dynamics of epigenetic landscapes influence different regulatory potentials by changing 
the accessibility of chromatin regions. The Assay for Transposase Accessible Chromatin using 
sequencing (ATAC-seq) provides an efficient way of profiling chromatin accessibility with small 
numbers of cells isolated from a large human cohort (Buenrostro et al., 2013). I performed 
differential transcription factor binding sites (TFBS) enrichment analysis in the regulatory 
elements involved in neurogenesis from fetal brain tissues. I identified transcription factors (TFs) 
known and unknown to be involved in neural stem cell proliferation and neural differentiation. I 
also performed chromatin accessibility QTLs in hNPCs and their differentiated neurons from 92 
donors at 14-21 gestation weeks. I identified significant genetic effects on 988/1,839 
neuron/progenitor regulatory elements, with highly cell-type and temporally specific effects. By 
integrating cell-type specific caQTLs and brain-relevant genome-wide association data, we were 
able to fine-map and identify regulatory mechanisms underlying non-coding neuropsychiatric 
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disorder risk loci. I also combined genotype data with the allelic chromatin accessibility/gene 
expression to identify putatively imprinted regulatory elements and genes using a likelihood ratio 
test based on the beta-binomial distributions. We identified 44/20 imprinted regulatory elements 
and 33/33 imprinted genes in neurons/progenitors. Combining imprinted regulatory elements 
and imprinted genes, we predicted cell-type specific imprinted isoforms in neurons and neuron-
specific imprinted promoters that involved in parent-of-origin dependent cerebral palsy. These 
studies identified molecular mechanisms underlying common genetic variants and inferred 
genomic imprinting involved in complex diseases, providing a better understanding of the 
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CHAPTER 1 INTRODUCTION 
1.1 Genome-wide association studies identified common genetic variation affecting the 
risk for multiple neuropsychiatric disorders. 
 
Genome-wide association studies have been widely performed for many disease-related 
traits in the past decades, especially for neuropsychiatric disorders, such as schizophrenia 
(SCZ), bipolar disorder (BD), major depressive disorder (MDD), and attention deficit 
hyperactivity disorder (ADHD). 108 loci were found to be genome-wide significantly (p < 5e-08) 
associated with the risk for SCZ (Consortium & Schizophrenia Working Group of the Psychiatric 
Genomics Consortium, 2014), more recently, a meta-analysis based GWAS study added 
another 50 loci at genome-wide significance (Pardiñas et al., 2018). In addition, 44 loci were 
identified by MDD GWAS (Wray et al., 2018), 30 loci were identified by BD GWAS (E. Stahl & 
Bipolar Working Group of the Psychiatric Genomics Consortium, 2019) and 16 loci were 
identified by ADHD GWAS (Demontis et al., 2019). There has also been progress made in 
combining samples across  neuropsychiatric disorders (Cross-Disorder Group of the Psychiatric 
Genomics Consortium. Electronic address: plee0@mgh.harvard.edu & Cross-Disorder Group of 
the Psychiatric Genomics Consortium, 2019). These studies identified genetic loci creating risk 
for neuropsychiatric disorders, providing a genome-wide view of the genetic architecture of 
complex diseases and causal footholds into understanding disease etiology.
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1.2 Challenges of exploring the molecular mechanisms underlying disease risk loci 
More and more genetic risk loci were found by GWAS because of increasing sample 
sizes, however, it is still unclear which are the causal variants in most loci and the molecular 
mechanisms underlying these loci. Identifying causal variants and molecular mechanisms will 
benefit from experiments that validate the biological functions of these variants in complex traits.  
There are several challenges to solve this uncertainty: 1) it is hard to identify common genetic 
variation with small sample sizes and in regions of high linkage disequilibrium with highly 
correlated SNPs (single nucleotide polymorphisms); 2) it is difficult to identify the underlying 
molecular mechanisms because most disease loci are in the non-coding regions and can be 
cell-type/context specific. 
The effect sizes of common genetic variants are usually small for most human traits, and 
only a limited proportion of trait heritability is explained by genome-wide significant loci (usually 
below 15%) (Kanazawa et al., 2017; Manolio et al., 2009). With the sample sizes increased, 
more and more heritability can be explained based on the previous power studies (Gibson, 
2010; Park et al., 2010). In recent studies, more than 30% of heritability can be explained for 
many complex traits (Speed et al., 2017). Based on this, association studies need a large 
sample size to identify genome-wide significant genetic variants. Even though hundreds of loci 
were discovered by GWAS on neuropsychiatric disorders, it is still worth enlarging the sample 
sizes by nation-wide and international collaborations to understand the genetic contribution to 
neuropsychiatric disorders. 
Linkage disequilibrium (LD) is calculated by the alleles from some SNPs that are co-
occuring in a population in certain genomic regions more often than expected by chance (Bush 
& Moore, 2012). The LD correlations between SNPs in a population can be measured by R2, 
which is the squared coefficient of correlation between SNPs. The LD block can be estimated by 
high R2 between adjacent loci and the most significant SNP associated with a trait in the LD 
block is the index GWAS SNP. However, other SNPs are correlated with index GWAS SNPs in 
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the LD regions, meaning that these SNPs have similar association statistics in the locus, making 
it difficult to identify the causal genetic variant within the risk locus. Improving genotype 
imputation is another way to better identify the causal variants. Genotype imputation is the 
estimation of genetic variants that are not directly genotyped using LD structures from the 
reference panel of genetic variants by whole genome sequencing (WGS), such as the 1000 
genomes project (1000 Genomes Project Consortium et al., 2015). Imputation is more accurate 
when the reference panel is representative of all the variants in a population, meaning a deeper 
WGS of more people will improve the accuracy of imputation. The recent new 
(https://www.nhlbiwgs.org/) high-depth WGS can improve the accuracy of genotype imputation 
and enable better discovery of common genetic variants, however, even with ever-improving 
reference panels it is still difficult to identify causal common variants due to the high LD 
correlations. 
The majority of loci discovered by GWAS for complex traits are mapped to the non-
coding regions of the genome (F. Zhang & Lupski, 2015). One hypothesis is that the genetic 
variants influence the risk for diseases by changing gene regulation. So one mechanism would 
be the genetic variants affect gene expression by altering DNA sequence motifs for transcription 
factors (TFs) at their binding sites (TFBS), which are commonly found at regulatory elements 
such as enhancers and promoters. One example known from previous literature is for 
Parkinson’s disease risk genetic variant rs356168. The A allele at rs356168 (protective allele) 
shows efficient binding of the brain-specific TFs EMX2 and NKX6-1 at the distal intron-4 
enhancer, which results in a suppressed distal enhancer and consequently lower expression of 
SNCA associated with a reduced risk for Parkinson’s disease. In contrast, the G allele at 
rs356168 (risk allele) shows reduced TF binding, which results in an active distal enhancer 
leading to increased expression of SNCA and increased risk for Parkinson’s disease (Soldner et 
al., 2016). This example demonstrates an experimentally validated mechanism of a non-coding 
risk variant.  
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1.3 Chromatin accessibility and genetic regulation (previous eQTL/caQTL studies) 
One of the difficulties to understand the mechanisms underlying complex trait 
associations is that the GWAS loci are usually located in the non-coding genomic regions, and it 
is difficult to identify the molecular effects of noncoding variants. Missense and nonsense coding 
mutations can be characterized by protein biochemistry, however, it is challenging to predict the 
mechanisms by which noncoding variants act to affect gene regulation (Ward & Kellis, 2012). To 
solve the problem, we can use other molecular traits to get more mechanistic information at the 
loci by association studies, including gene expression (eQTL) and splicing (sQTL), chromatin 
accessibility (caQTL), chromatin-chromatin interaction, histone modification, and protein 
expression. Compared to GWAS studies, one advantage for molecular trait (quantitative trait 
loci) studies is that they can be done with fewer than one hundred individuals, given GWAS 
usually require thousands of individuals (Q. Q. Huang et al., 2018). A possible reason is that 
molecular traits are more directly affected by genetic variants than the complex phenotypes in 
patients or healthy individuals. eQTLs and sQTLs link the common genetic variants to specific 
genes (or splicing events), so the colocalization between e(s)QTLs and GWAS is a good way to 
identify genes that are involved in complex traits. Even though consortiums, like GTEx 
(Genotype-Tissue Expression project), ENCODE, PsychENCODE (C. A. Davis et al., 2018; 
ENCODE Project Consortium, 2012; GTEx Consortium et al., 2017) as well as other studies  
(Walker et al., 2019; D. Wang et al., 2018), contribute to the growth of e(s)QTL studies, there 
are limited GWAS loci can be clearly understood. To better understand the effects of non-coding 
variants on genetic regulation, chromatin accessibility and histone modification can be used. 
Regulatory elements in the genome have a DNA conformation that is open or accessible to 
transcription factor binding, whereas most other genomic regions have lower accessibility. And 
histone modifications can be used to annotate regulatory elements such as enhancers and 
promoters (Creyghton et al., 2010; Ernst & Kellis, 2012; Gates et al., 2017). Histone acetylation 
QTL (haQTLs) and chromatin accessibility QTL (caQTLs) are powerful tools employed to 
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identify the effect of genetic variation on non-coding regulatory elements and provide further 
understanding of upstream regulatory mechanisms of eQTLs at both bulk and cell-type specific 
levels (Bryois et al., 2018; Degner et al., 2012; Gate et al., 2018; Schwartzentruber et al., 2018; 
A. Tehranchi et al., 2019; A. K. Tehranchi et al., 2016; D. Wang et al., 2018). Profiling 3-
dimensional chromatin interactions also contributes to the connection between non-coding 
genetic variation and genes they regulate in developing and adult brain tissue (Won et al., 
2016). Most of these resources focus on bulk tissue rather than specific cell-types, however, the 
regulatory impact of disease-associated loci may be most evident in cell types relevant to each 
disease (Strober et al., 2019). Moreover, some cell-type specific QTLs can not be discovered in 
bulk tissues (Strober et al., 2019). 
In addition, it is hard to identify the colocalization between QTLs and GWAS loci. A 
major challenge in integrating caQTLs and GWA hits is LD, which produces an inherent non-
random association between two independent loci. First, LD makes it harder to identify the 
causal SNPs, because the observed significant SNPs could be a result from sharing LD with the 
real causal SNP. Second, it increases the chances for false positive co-localization, which 
means the SNP is chosen because it is in close proximity of two independent loci that 
independently influence the two traits. Multiple statistical methods can be used to determine 
colocalization based on the assumption that LD structures are the same between GWAS and 
QTL studies, such as coloc (Giambartolomei et al., 2018), RTC (Nica et al., 2010), Sherlock (Xin 
He et al., 2013), QTLMatch (Plagnol et al., 2009) and conditional analysis between QTLs and 
GWAS data (Civelek et al., 2017). However, the sensitivity and accuracy of these methods still 
need to be improved by including the LD structures in the models. A recent fine-mapping 
method eCAVIAR (Hormozdiari et al., 2016) can address multiple causal variants in the same 
loci and different LD structures from different studies. But eCAVIAR is a computationally 
intensive method that takes a lot of time to identify multiple causal variants computationally. So 
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fine-mapping methods need to be improved to identify multiple causal variants with different LD 
structures in a more efficient way. 
Previous eQTL studies showed a high proportion of shared regulatory variants across 
different tissues, and only 10-30% of the eQTLs are tissue-specific (Baran et al., 2015). 
However, there are multiple cell types in different tissues and many cell types are shared in 
different tissues, which may cause the eQTLs to be shared in these tissues. A recent study 
showed cell-type specific eQTLs contribute to eQTL tissue specificity and improved GWAS-QTL 
colocalization (Kim-Hellmuth et al., 2020), indicating that the high level of sharing eQTLs in 
tissues may reflect the wide mix of cell types in whole tissues, and underestimate eQTL 
specificity at cell type levels (Umans et al., 2020). In addition, some genetic regulation may only 
be present under specific conditions, such as in response to the immune stimulus (Alasoo et al., 
2018; Fairfax et al., 2014). Many context-specific eQTLs/caQTLs (chromatin accessibility 
quantitative trait loci) are found only in stimulated cells and showed colocalization with disease-
related GWAS loci. 
1.4 Genetic changes implicate alterations during fetal brain development in risk for 
neuropsychiatric disorders 
 
Cortical neurogenesis is approximately 143 days (7 to 27 postconceptional weeks (pcw)) 
in humans, which continues throughout embryonic and fetal development (Silbereis et al., 
2016). During cortical neurogenesis, the cortex can be divided into laminae enriched for specific 
cell types (Figure 1.1). The neural progenitor cells from lower laminae, ventricular and 
subventricular zones, are capable of differentiating into neurons. These neurons migrate to the 
upper laminae,  subplate and cortical plate, during mid-fetal development (Rakic, 1988). The 
ventricular zone (VZ) enriched for neuroepithelial cells, which are the neural progenitor cells for 
all neurons and astrocytes of the central nervous system. Another neurogenic proliferative 
compartment called the subventricular zone (SVZ) appears above the VZ and enlarges 
dramatically over the course of early and mid-fetal development. Early on in embryonic 
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neurogenesis, neuroepithelial progenitor cells of the VZ transition into another form of neural 
stem or progenitor cell, called radial glia (RG), which extend a very long process to the pial 
surface of the expanding neocortical wall (Bystron et al., 2006; Howard et al., 2008; Lui et al., 
2011; Taverna et al., 2014). RG cell bodies largely reside in the VZ and SVZ, where they divide 
symmetrically or asymmetrically, giving rise to a daughter RG cell and either an intermediate 




Figure 1.1: Cortical laminae can be marked by specific cell types due to the development pattern. The 
earliest produced neurons migrate to the upper cortical laminae. Subsequently neurons migrate to 
successively more superficial laminae creating an inside out order of migration. 
 
Many patients with neuropsychiatric disorders have structural changes in the cortex 
(Opel et al., 2020). Hence, by studying how genetic variants change gene expression during the 
differentiation from progenitors to neurons, we can better illustrate the genetic regulatory 
mechanisms underlying neuropsychiatric disorders. Our previous study identified differentially 
accessible chromatin regions using the progenitor-enriched regions (the germinal zone, or GZ) 
and the neuron-enriched regions (the cortical plate, or CP) from fetal brain tissues, identifying 
regulatory mechanisms in this differentiation process (de la Torre-Ubieta et al., 2018). However, 
the ability to connect human allelic variation to longitudinal changes in regulatory architecture 
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that occur during this foundational stage of human brain development is severely limited by the 
inaccessibility of brain tissue from the same individual over multiple time points. Chapter 3 of 
this thesis seeks to tease out this problem. 
1.5 Using primary human neural progenitor cells (phNPCs) we can mimic human 
neuronal differentiation 
 
Neural progenitor cells in the fetal cortex are capable of producing different cells that 
make up the brain, but here we focus on the production and differentiation of cortical neurons 
which is critical for cortex development (Martynoga et al., 2012; Nowakowski et al., 2016). The 
radial unit hypothesis is used to explain the relationship between cortical neurogenesis and the 
expansion of the cortex. According to the radial unit hypothesis, cortical thickness is determined 
by the number of neurons differentiating from adjacent radial glia fibers (radial units), but cortical 
surface area is related to the early proliferation of progenitor cells forming radial units (Rakic, 
2000). Previous studies showed that many neuropsychiatric disorders are associated with 
structural changes in the cortex. Patients with schizophrenia have a significantly thinner cortex 
and smaller surface area (van Erp et al., 2018). In autism patients, however, cortical surface 
area is increased in early infancy (Hazlett et al., 2017). Hence, early neural proliferation and 
differentiation are critical for shaping the human brains. Comprehending the underlying 
mechanisms that regulate neural proliferation and differentiation will help us better understand 
the pathogenesis of neuropsychiatric disorders. 
Furthermore, genes associated with schizophrenia are expressed at a higher level in the 
cortex during fetal developmental stages (Gulsuner et al., 2013; Xu et al., 2012). Changes in 
protein interactions during the late mid-fetal period may be common for different types of 
autisms (Lin et al., 2015). In addition, the disease associated genes are likely to be enriched for 
functions that are related with the developing fetal brain: neural development and differentiation, 
axon guidance, transcription factor and gene regulation activity (Johnson et al., 2009). 
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Therefore, understanding the regulatory mechanisms of fetal cortical development is key to 
illustrating the pathology of neuropsychiatric disorders.  
phNPCs contain multiple types of cortical progenitors, including ventricular glia and outer 
radial glia (Dehay & Kennedy, 2007; D. V. Hansen et al., 2010). These progenitors can be used 
to model proliferation and differentiation involved in fetal neurogenesis. First, phNPCs have the 
similar developmental timescale and gene expression pattern with the cortical development 
(Genevieve Konopka et al., 2009; Stein et al., 2014). Second, phNPCs can be used to develop 
and validate in vitro models of neuropsychiatric disorders, such as autism disorders (Genevieve 
Konopka et al., 2009) and neurodegenerative diseases (Rosen et al., 2011; Wexler et al., 2011). 
In addition, phNPCs could be modified by virus labeling and immunocytochemistry staining for 
high-throughput screening. Although human induced pluripotency cells (hiPSCs) have been 
used to model the functions involved in neurogenesis (Dolmetsch & Geschwind, 2011; S. Kang 
et al., 2017), generating hiPSCs is often expensive and time-consuming. In vitro culture of 
hiPSC-derived neural progenitors and neurons could increase the heterogeneity of the cells, 
resulting in lower similarity with the in vivo system (Stein et al., 2014). The phNPCs we use for 
this proposal are derived from the fetal brain cortex, which are more similar to the in vivo brain. 
By growing and differentiating the phNPCs, we can model fetal cortical development and 
analyze the regulatory mechanisms of gene expression during this stage. A better 
understanding of the gene regulation during cortical development will contribute to our 
knowledge of neuropsychiatric disorders, because many neuropsychiatric disorders are 
associated with structural changes in the cortex (Hazlett et al., 2017; van Erp et al., 2018). 
1.6 Genomic imprinting during human neuronal differentiation 
 
Genomic imprinting is a process that leads to the preferential expression from either the 
maternally or paternally inherited allele of certain genes or regulatory elements. Imprinted genes 
are important in mammalian fetal growth and development (Reik & Walter, 2001). More 
importantly, more imprinted genes are specifically expressed in the brain (Ho-Shing & Dulac, 
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2019). Dysregulation of these genes in the brain can lead to developmental disability, cognitive 
impairment, speech impairment, and behavioral problems (H. J. Lee et al., 2019). Imprinted 
genes may be expressed differently during neuronal development. In mouse, imprinted genes 
are expressed  differently between fetal brain and adult brain (Gregg et al., 2010). Therefore, 
genomic imprinting needs to be detected in different cell types for understanding gene 
expression and function of imprinted genes during brain development.  
Even though mouse models are usually used to study the imprinted genes in brain 
development and neurodevelopmental disorders, these models may not have the same cellular 
phenotypes with humans because of the different imprinted regulation between mouse and 
human (Caspary et al., 1999). hNPCs and their differentiated neurons are better models to 
study human neuronal differentiation, because neural progenitors and neurons are key cell 
types during human brain development. Combining genotype date and high-throughput 
sequencing data (RNA-seq and ATAC-seq) for gene expression and chromatin accessibility, we 
can infer imprinted genes and imprinted regulatory elements in neural progenitors and neurons, 
which will improve the understanding of epigenetic changes during human brain development. 
In Chapter 2, I identified the transcription factors (TFs) involved in neurogenesis using 
ATAC-seq from segmented fetal brain tissues. In Chapter 3, I mapped cell-type specific genetic 
effects on chromatin accessibility and predicted regulatory mechanisms underlying brain-related 
traits during human neuronal differentiation. In Chapter 4, I inferred imprinted genes and 





CHAPTER 2 DETECTION OF DIFFERENTIAL TRANSCRIPTION FACTOR BINDING TO 
REGULATORY ELEMENTS DURING HUMAN NEUROGENESIS1 
 
2.1 Introduction  
The highly structured mammalian cerebral cortical wall is divided into laminae enriched 
for distinct cell-types and functions during cortical neurogenesis (Bystron et al., 2008; Greig et 
al., 2013; Lui et al., 2011; Molnar et al., 2014). Neural progenitors, found in the ventricular and 
subventricular zones differentiate into neurons, which migrate to the subplate and cortical plate 
during mid-fetal development (Rakic, 1988). Decades of comparative cross-species studies 
leave little doubt that the expansion of the cerebral cortex in primates plays a major role in the 
evolution of human cognition (Krasnegor et al., 1997), and yet we are only beginning to 
understand the molecular and cellular basis of this dramatic process (Bae et al., 2015; Hevner 
and Haydar, 2012; Lodato et al., 2015; Taverna et al., 2014) . It has become clear that it is gene 
regulation, rather than protein sequence that plays the predominant role in human brain 
evolution (King and Wilson, 1975; Varki et al., 2008). Therefore, acquiring a more complete 
understanding of the gene regulatory mechanisms that guide molecular programs involved in 
neurogenesis (Chenn and Walsh, 2002; Florio et al., 2015; Johnson et al., 2015; Lui et al., 
2014; Miller et al., 2014; Pollen et al., 2015), a process central to the expansion of the primate 
neocortex and the evolution of human cognition, will allow insights into molecular mechanisms 
 
1 This chapter previously appeared as an article in the Journal of Cell. The original citation is as follows: 
de la Torre-Ubieta, L., Stein, J. L., Won, H., Opland, C. K., Liang, D., Lu, D., & Geschwind, D. H. (2018). 




generating uniquely human cognitive capabilities and their dysregulation in neuropsychiatric 
disease (Bae et al., 2015; Geschwind and Rakic, 2013). 
In this regard, gene expression in the developing human cortex is starting to be well 
defined based on transcriptome analysis of bulk tissue (Kang et al., 2011), lamina (Fietz et al., 
2012; Miller et al., 2014), and even single cells (Camp et al., 2015; Darmanis et al., 2015; 
Johnson et al., 2015; Pollen et al., 2015). Yet, compared with mouse, genomic regions 
regulating gene expression, such as enhancers and promoters, are not well defined as they 
often lie in poorly annotated non-coding regions of the genome (Gray et al., 2017; Visel et al., 
2013). Defining the regions that regulate transcriptional programs during human corticogenesis 
is of great importance (Psych et al., 2015), since most human specific genetic variation and risk 
loci for neuropsychiatric diseases are found in these non-coding regions and likely have 
regulatory functionality, including acting as enhancers or repressors (Lee and Young, 2013; 
Ward and Kellis, 2012). An improved understanding of this function would substantially inform 
our understanding of human brain evolution and neuropsychiatric disease risk. 
Enhancers and promoters are often found in open or accessible regions of chromatin 
where DNA-binding proteins like transcription factors (TFs) preferentially bind (Nord et al., 2015; 
Zhou et al., 2011). The localization and degree of chromatin accessibility in a population of cells 
can be measured genome-wide using DNAse-I hypersensitivity followed by short-read 
sequencing (DNase-seq) (Boyle et al., 2008). More recently, higher-throughput methods for 
measuring chromatin accessibility have been developed wherein a transposase carrying 
sequencing adapters preferentially inserts and marks accessible regions of the chromatin 
(Assay for Transposase-Accessible Chromatin using sequencing [ATAC-seq]) (Buenrostro et 
al., 2013). In addition, unbiased methods such as Hi-C, have been developed to profile genome-
wide chromatin interactions aiding the identification of the cognate gene of an enhancer 
(Lieberman- Aiden et al., 2009; Won et al., 2016). Regions of accessible chromatin in bulk 
human fetal brain and adult brain have previously been identified using DNase-seq (Roadmap 
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Epigenomics et al., 2015). However, regulatory elements involved in human neurogenesis have 
not yet been identified because a direct comparison of accessibility between the neural 
progenitor-enriched and post-mitotic neuron-enriched cortical laminae has not been conducted. 
Chromatin regulators, including members of the BAF complex, histone modifiers, and TFs have 
been implicated as key regulators of neuronal differentiation and function, further highlighting 
the need to define the cis-regulatory elements governing corticogenesis (Geschwind and Rakic, 
2013; Gray et al., 2017; Nord et al., 2015; Pereira et al., 2010; Ronan et al., 2013; Visel et al., 
2013). 
Here, we perform ATAC-seq on the germinal zone and subplate/cortical plate in the 
developing human brain to identify regulatory elements involved in neurogenesis or neural 




Since TFs are key drivers of gene expression and cell fate determination including 
neuronal differentiation (Guillemot, 2007; Nord et al., 2015; Yang et al., 2011), we predicted that 
TF binding within accessible chromatin would drive tissue specific differentiation processes in 
the developing cortex. This leads to the expectation that TF motifs found more often in germinal 
zone (GZ) accessible regions would be enriched in TFs known to promote neural progenitor 
maintenance and proliferation (called here gzTFs), whilst those motifs found more often in 
cortical plate (CP) accessible regions would be enriched in TFs involved in neurogenesis and 
neuronal maturation (called here cpTFs). Observing such coordination in our data would provide 
another level of validation of the functional importance of chromatin accessibility as well as 
permit identification of novel TFs driving the programs involved in human cortical neurogenesis.  
We conducted a differential motif enrichment analysis to identify predicted TF binding 
sites (TFBSs) present more often in GZ>CP peaks as compared to CP>GZ peaks (gzTFs), or 
vice versa (cpTFs; Experimental Procedures). After filtering for TFs expressed in the developing 
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cortex, we identified 97 gzTFs and 26 cpTFs using a logistic regression framework (FDR 
adjusted pvalue < 0.05; Figure 2.1). gzTFs included SOX2 and PAX6, canonical markers of 
radial glia in the dorsal telencephalon known to regulate neural stem cell self-renewal (Estivill-
Torrus et al., 2002; Graham et al., 2003; Sansom et al., 2009; Tuoc et al., 2009) and several 
TFs known to be required for neural progenitor expansion or proliferation in developing cortex, 
including ARX, EMX1/2, LHX2, KLF4, NR2F1 and SP2 (Bishop et al., 2003; Chou and O'Leary, 
2013; Colasante et al., 2015; Hsu et al., 2015; Kitamura et al., 2002; Liang et al., 2013; Naka et 
al., 2008; Qin and Zhang, 2012), and NFYA/B , known to function as an activator of cell cycle 
genes (Benatti et al., 2011) (Figure 2.1A). Notably, gzTFs as a group were enriched in the 
homeodomain class of TF, which are implicated in neural stem cell patterning and neural 
progenitor fate specification (Guillemot, 2007) (Figure 2.1B). 
Conversely, cpTFs were enriched in pro-neural basic helix-loop-helix (bHLH) factors 
including NEUROG2 and NEUROD2, which are known to promote neuronal differentiation 
(Bertrand et al., 2002; Imayoshi and Kageyama, 2014), whereas gzTFs were depleted in this 
class (Figures 2.1C and 2.1D). Other notable examples of cpTFs known to promote neuronal 
differentiation or maturity include REST (also known as NRSF), a canonical repressor of 
neuronal gene transcription (Ballas et al., 2005) and the bHLH gene BHLHE22 that is required 
for a real identity and proper circuit formation in the dorsal telencephalon (Joshi et al., 2008; 
Ross et al., 2012). Of all identified TFs, 68% of the gzTFs and 88% of the cpTFs were 
differentially expressed between GZ and CP in fetal brain, indicating their dynamic regulation 
between these regions during cortical development (FDR adjusted p-value < 0.05 for differential 
expression). Together, these results demonstrate that differential motif enrichment analysis in 
differentially accessible chromatin accessibility peaks identifies TFs known to be involved in 
neural stem cell proliferation and neural differentiation and suggests additional TFs that were 
previously unknown to be involved in these processes. 
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As a proof of principle, we conducted a differential motif enrichment analysis between 
fibroblasts and human embryonic stem cells (hESCs) using the same logistic regression 
framework, identifying the major known pluripotency-associated transcription factors (Buganim 
et al., 2013), demonstrating the validity of this approach (Figure 2.2). 
2.3 Discussion  
 
Here we have performed the first comprehensive assessment of chromatin accessibility 
during human cortical neurogenesis. We identify candidate TFs regulating these genes to inform 
our understanding of human genetic disorders and brain evolution. The importance of regulatory 
sequences, in particular enhancers, to restrict gene expression spatially or temporally has been 
well documented (Roadmap Epigenomics et al., 2015; Visel et al., 2013). Such data can be 
used in multiple ways to explore biological pathways or drive gene expression to specific cell 
types or periods.  
A key component of the regulatory networks governing corticogenesis are the TFs that 
bind to regulatory elements to repress or activate gene expression. Often TF prediction efforts 
rely exclusively in motif prediction, not incorporating chromatin accessibility or chromatin 
interaction, which would inform TF-target networks (Rackham et al., 2016). Our analysis 
identifies many TFs known to orchestrate neurogenesis and differentiation, including Sox, 
homeodomain, and bHLH family members, among others (Bertrand et al., 2002; Guillemot, 
2007; Imayoshi and Kageyama, 2014). Based on these data we predict roles in cortical 
neurogenesis for several dozen other TFs not previously implicated in this process. ChIP-seq 
experiments will be necessary to assess individual TF gene relationships (Johnson et al., 2007) 
and understand the downstream molecular mechanisms, but they rely on highly specific 
antibodies for native in vivo validation, which are not yet available for many of these TFs. Since 
TFs are key drivers of cell fate, modulating the expression of these neurogenesis-related TFs 
may be the key to generating mature neurons quicker and at higher fidelity in neural stem cell 
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systems, which currently differentiate slowly and in a heterogeneous manner (Stein et al., 2014; 
















Figure 2.1 Predicting TFs Involved in Neural Progenitor Proliferation and Neurogenesis. (A and C) TFs 
with significant differential enrichment of conserved motifs in DA peaks. The statistical test identifies TFs 
likely involved in neural progenitor proliferation and maintenance (gz TFs) (A) or neurogenesis and 
maturation (cpTFs) (C). (B and D) Enrichment of TF classes for gaTE (B) or cpTFs (D). 
 
 
Figure 2.2 TFs with significant differentially enriched conserved motifs present more often in hESC > 





Fetal tissue was obtained from the UCLA Gene and Cell Therapy Core according to IRB 
guidelines from 3 donors (post-conception weeks 15,16,17) following voluntary termination of 
pregnancy. Coronal sections were taken from dissociated tissue that visually appeared cortical. 
Under a dissection microscope, the coronal sections were cut with a razor blade along the less 
dense intermediate zone to divide the tissue into two segments from each donor (1) GZ: the 
neural progenitor rich region encompassing the ventricular zone, subventricular zone, and 
intermediate zone and (2) CP: the neuron rich region encompassing the subplate, cortical plate, 
and marginal zone. For each donor and tissue, at least three replicates were processed for 
ATAC-seq and RNA-seq. 
ATAC-seq library preparation and pre-processing 
ATAC-seq processing followed the original protocol (Buenrostro et al., 2013), which 
involves enzymatic dissociation of tissue using papain inactivated by ovomucoid followed by 
aliquoting of 50,000 cells, nuclear isolation using an IGEPAL solution, transposition using Tn5 
transposase (Illumina Nextera kit), barcoding and amplification (8-11 cycles), quality control via 
gel electrophoresis, quantification via Kapa Library Quantification Kit, and massively parallel 50 
bp paired end (PE) sequencing on an Illumina HiSeq2000 to acquire ~25M fragments per 
sample. For each donor, GZ and CP samples were dissected, library prepped, and sequenced 
within the same batch to prevent batch effects correlated with the biological condition of interest. 
Sequencing files from each sequencing lane were de-multiplexed and poor quality reads 
were excluded (PF=1 reads were retained). Reads were then mapped to the human genome 
including decoy sequences (hg19; 1000 Genomes Project Phase 2 reference assembly) using 
bwa mem (Li and Durbin, 2009) (v0.7.12). Optical and PCR duplicates were then removed using 
PicardTools (v1.128). De-duplicated BAM files from the same sample were merged from 
separate lanes and PicardTools was again used to remove duplicate reads. Only uniquely 
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mapped reads mapping to chr 1-22 and X were kept (mitochondrial genome, Y chromosome, 
and unmapped contigs were removed). Peaks were called for each sample using MACS2 
(Zhang et al., 2008) (v2.1.0.20140616). Peaks that overlapped with ENCODE blacklisted 
regions 
(http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeMapability/wgEncode
DacMapabilityConsensusExcludable.bed.gz) were removed (Consortium, 2012). ATAC-seq 
peaks are available through GEO (GSE95023). 
ATAC-seq differential accessibility analysis 
R version 3.1.1 (2014-07-10) was used for all subsequent analyses. The DiffBind (Ross-
Innes et al., 2012) package (v1.10.2) was used to find high confidence peaks present in at least 
40% of samples. The union across samples of those remaining peaks (called peaksets in 
DiffBind, but hereafter simply referred to as peaks) was used for subsequent analyses. The 
number of reads within each peak was counted and then normalization factors for each peak 
across samples were calculated accounting for GC content, peak width, and total number of 
unique non-mitochondrial fragments sequenced using conditional quantile normalization 
(Hansen et al., 2012) from the cqn package (v1.10.0). Normalization by GC content within 
peaks was performed to offset observed biases of GC content on differential accessibility. 
Differential accessibility across tissue type was calculated using a negative binomial regression 
with normalization based on the size factors from cqn and implemented in DEseq2 (Love et al., 
2014) (v1.4.5) with default parameters (fitType="parametric",test="Wald"). In order to find 
differentially accessible peaks across tissue type controlling for donor differences, the statistical 
model used included a regressor for tissue type (GZ or CP) and a factor regressor for the 3 
donors included in the analysis.  
Differential transcription factor binding analysis 
Potential transcription factor binding sites were called in the human genome using 
TFBSTools (v1.4.0) with a minimum score threshold of 80% based on position weight matrices 
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from the JASPAR2016 (Mathelier et al., 2016). Core database, selecting vertebrates as the 
taxonomic group. Only the most recent version of the PWM for a given TF was used. To select 
regions of the genome that are highly conserved amongst vertebrates, and likely functional, 
regions of the genome with 100-way phastCons (Pollard et al., 2010) scores > 0.4 in regions ≥ 
20 bp were saved (downloaded from UCSC genome browser). Only called TFBS sites within 
conserved regions were retained for further analyses. Differential motif enrichment analysis was 
performed using a logistic regression model to identify motifs present more often in GZ>CP 
peaks as compared to CP>GZ peaks, or vice versa. Logistic regression explicitly controlled for 
differences in peak width and peak conservation between GZ>CP and CP>GZ differentially 
accessible peaks. The analysis was implemented in R as: glm(TFBS ~ GZCP + peakwidth + 
conservedbppercent, family = "binomial"). The dependent variable (TFBS) was a binary 
representation of whether each differentially accessible peak contained a motif of a TF or not. 
 
The independent variable of interest marked whether a peak was GZ>CP (GZCP=1) or 
CP>GZ (GZCP=0). Other covariates included peak width (peakwidth) and the percentage of the 
peak with conservation (conservedbppercent) as defined above. Significant differential motif 
enrichment was determined by a FDR adjusted P-value < 0.05 threshold of the GZCP covariate 
as well as evidence of expression within the RNA-seq data. gzTFs were defined as significant 
differentially enriched motifs present more often in GZ>CP as compared to CP>GZ peaks, 
whereas cpTFs were defined as significant differentially enriched motifs present more often in 
CP>GZ as compared to GZ>CP peaks. The class of each TF was acquired through 
JASPAR2016 and a Fisher’s exact test was used to calculate if a significant enrichment or 
depletion of that class was present in significant gzTFs or cpTFs as compared to all TFs found 






CHAPTER 3 CELL-TYPE SPECIFIC EFFECTS OF GENETIC VARIATION ON CHROMATIN 
ACCESSIBILITY DURING HUMAN NEURONAL DIFFERENTIATION2 
 
3.1 Introduction 
Genome-wide association studies (GWAS) have revealed hundreds of common single 
nucleotide polymorphisms (SNPs) that are associated with risk for neuropsychiatric disorders 
and brain structures (Cross-Disorder Group of the Psychiatric Genomics Consortium, 2013; 
Geschwind & Flint, 2015; Grasby et al., 2018; Sullivan et al., 2018). A crucial next step is to 
understand the molecular mechanisms by which these variants impact disease risk and brain 
development (Sullivan & Geschwind, 2019). This is complicated by many factors, including: (1) 
risk loci are often comprised of many SNPs in high linkage disequilibrium (LD) and thus the 
causal variant(s) are not known (Barešić et al., 2019), (2) most risk loci have been mapped to 
non-coding regions with unknown, but presumed gene regulatory function (P. H. Lee et al., 
2018), (3) it is not known in which cell-type(s), tissue-type(s), or developmental time period(s) 
that a genetic risk variant exerts its effects (Gamazon et al., 2018). Nevertheless, a commonly 
assumed model to explain molecular mechanisms underlying risk loci is that non-coding risk 
alleles disrupt transcription factor (TF) binding motifs within cell-type specific regulatory 
elements (REs) leading to alterations in gene expression and downstream impacts on risk
 
2 This chapter previously appeared as an article in the Journal of BioRxiv. The original citation is as 
follows: Liang, D., Elwell, A. L., Aygün, N., Lafferty, M. J., Krupa, O., Cheek, K. E., Courtney, K. P., 
Yusupova, M., Garrett, M. E., Ashley-Koch, A., Crawford, G. E., Love, M. I., de la Torre-Ubieta, L., 
Geschwind, D. H., & Stein, J. L. (2020). Cell-type specific effects of genetic variation on chromatin 
accessibility during human neuronal differentiation. In Cold Spring Harbor Laboratory (p. 
2020.01.13.904862). https://doi.org/10.1101/2020.01.13.904862 
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(Albert & Kruglyak, 2015; Nord & West, 2019). Thus, understanding tissue- and cell-type 
specific regulatory mechanisms are essential for moving from genetic association to a 
meaningful biological understanding.  
With this in mind, several consortia including ENCODE, GTEx and PsychENCODE have 
taken major steps to build maps of non-coding genome function across the body (C. A. Davis et 
al., 2018; ENCODE Project Consortium, 2012; GTEx Consortium et al., 2017; PsychENCODE 
Consortium et al., 2015; D. Wang et al., 2018). These and other efforts have connected non-
coding genetic variation to genes they regulate in developing and adult brain tissue by profiling 
3-dimensional chromatin interactions and by measuring the impact of genetic variation on gene 
expression, termed expression quantitative trait loci (eQTLs) (Walker et al., 2019; D. Wang et 
al., 2018; Won et al., 2016). Although these studies are an important first step in connecting 
non-coding risk loci to their cognate genes, they do not elucidate how the gene is regulated via 
human genetic variation.  
Risk variants for multiple neuropsychiatric disorders are enriched in REs active at mid-
gestation in humans, during the peak of cortical neurogenesis (de la Torre-Ubieta et al., 2018). 
Histone acetylation QTL (haQTLs) and chromatin accessibility QTL (caQTLs) are powerful tools 
employed to identify the effect of genetic variation on non-coding REs and provide further 
understanding of gene regulatory mechanisms at both bulk and cell-type specific levels (Bryois 
et al., 2018; Degner et al., 2012; Gate et al., 2018; Schwartzentruber et al., 2018; A. Tehranchi 
et al., 2019; A. K. Tehranchi et al., 2016; D. Wang et al., 2018). However, the ability to connect 
human allelic variation to longitudinal changes in regulatory architecture that occur during this 
foundational stage of human brain development is limited by the inaccessibility of brain tissue 
from the same individual over multiple time points. Here, we leveraged a well validated model of 
in vivo human brain development based on the in vitro culture of primary human neural 
progenitors (Dolmetsch & Geschwind, 2011; Stein et al., 2014) to study the functional effects of 
allelic variation on chromatin architecture during neurogenesis. We measured chromatin 
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accessibility (Buenrostro et al., 2013) in neural progenitor cultures in a cell-type specific manner 
at two key stages of neural development, during progenitor proliferation (Ndonor= 76) and after 
differentiation using their labeled and sorted neuronal progeny (Ndonor= 61). We identified 
thousands of caQTLs and allele specific chromatin accessibility (ASCA) sites, the majority of 
which were highly stage/cell-type specific. We use the effects of these genetic variations to 
understand how disrupting TF binding motifs impact chromatin accessibility and gene 
expression, as well as to understand the cell-type specific regulatory mechanisms underlying 
risk for neuropsychiatric disorders. 
3.2 Results 
Profiling genome-wide chromatin accessibility in progenitors and neurons 
We generated primary human neural progenitor cell (phNPC) lines from 14-21 gestation 
week genotyped human fetal brain (N=92) using a neurosphere isolation method that results in 
cultures with high fidelity to the in vivo developing brain (G. Konopka & Wexler, 2010; Palmer et 
al., 2001; Rosen et al., 2011; Stein et al., 2014; Wexler et al., 2011) (Figure 3.1a; Methods). 
phNPCs were cultured and isolated at two stages for downstream experiments: progenitor cells 
and 8-week differentiated and sorted neurons (Supplemental Figure 3.1a-3.1b). Using 
immunofluorescence of neural cell markers, we found over 90% of the undifferentiated 
progenitor cells were positive for SOX2 and PAX6, indicating a highly homogenous population 
of radial glia cells (Figure 3.1a; Supplemental Figure 3.1c) (D. V. Hansen et al., 2010). After 
differentiation for 8 weeks, we FACS sorted the virally labeled differentiated neurons which 
showed typical neuronal morphology (Figure 3.1a; Supplemental Figure 3.1b and 3.1d; 
Methods). We performed ATAC-seq on intact nuclei and found that libraries were high quality 
based on a comparison of quality metrics relative to previous in vivo developing brain data, as 
well as a sensitivity analysis and nucleosome periodicity (Supplemental Figure 3.1e; 
Supplemental Figure 3.2a-2b; (Buenrostro et al., 2013; de la Torre-Ubieta et al., 2018; Orchard 
et al., 2020)). We quantified accessibility as batch effect-corrected reads within accessible 
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peaks normalized for GC content, peak length and sequencing depth (Supplemental Figure 
3.2c, e, f). We found higher correlations of chromatin accessibility from libraries derived from the 
same donors cultured at different times as compared to correlations across donors, though the 
difference was not significant in neurons (Supplemental Figure 3.2d). To ensure independence 
for subsequent analyses, we randomly selected one library from each donor for each cell-type 
(N_progenitor=76 and N_neuron=61) to identify accessible peaks (N=90,227; average peak 
length of 409 bp; Methods).  
To determine the in vivo relevance of these accessible peaks, we performed an overlap 
analysis with REs derived from different human tissues (Figure 3.1b), utilizing previously 
classified chromatin states from 93 in vivo tissues and cell types (Roadmap Epigenomics 
Consortium et al., 2015), including fetal brain (male and female). The accessible peaks 
generated here from progenitors and neurons most strongly overlap enhancers and promoters 
identified in brain germinal matrix and fetal brain tissue, followed by other brain regions such as 
anterior caudate and dorsolateral prefrontal cortex, indicating that these peaks derived from 
phNPC cultures were highly representative of the in vivo fetal brain. Principal component 
analysis of chromatin accessibility revealed that progenitor and neuron samples clearly separate 
along the first principal component (Figure 3.1c), indicating that cell-type was associated with 
the largest variability in global chromatin accessibility profiles (64.91% of variance explained). 
These results demonstrate that chromatin accessibility measured from phNPC cultures are 
representative of REs present in the developing human brain and that chromatin accessibility 
patterns are broadly different between progenitors and neurons, consistent with previous bulk 




Identifying cell-type specific regulatory elements during neuronal differentiation 
To reveal cell-type specific REs involved in neuronal differentiation, we performed an 
analysis to determine which peaks had significantly different chromatin accessibility between 
neural progenitors and neurons (Figure 3.1d; Methods). We identified 35,379 peaks with greater 
accessibility in progenitors than neurons (progenitor peaks; FDR < 0.05) and 44,729 peaks with 
greater accessibility in neurons than progenitors (neuron peaks; FDR < 0.05; Supplemental 
Table 3.1). At the promoter of SYN1, which was used to label neurons for sorting during 
differentiation, we observed considerably higher accessibility in neurons as compared to 
progenitors, as expected (LFC=-2.88, P-value=2.83e-55; Figure 3.1d). Among significant 
differentially accessible peaks, we found greater accessibility in progenitors at the promoters of 
genes highly or uniquely expressed in progenitors, including WNT2B, HOPX and the dorsal 
telencephalic marker gene EMX2 (Figure 3.1e) (Brunelli et al., 1996; Harrison-Uy & Pleasure, 
2012; Pollen et al., 2015; Simeone et al., 1992). Moreover, promoters of genes highly 
expressed in neurons, such as DCX, BDNF, CAMK2B and SYT13 (Fukuda & Mikoshiba, 2001; 
Polioudakis et al., 2019), showed greater chromatin accessibility in neurons (Figure 3.1d-3.1e).  
We identified the biological processes involved in differentially accessible peaks near 
protein-coding TSSs (2kb upstream and 1kb downstream from TSSs) during neuronal 
differentiation using Gene Ontology (GO) terms (Supplemental Figure 3.3a; (Ashburner et al., 
2000)). In promoter peaks more accessible in progenitors, we found an enrichment of GO terms 
related to known progenitor cell function, including neurogenesis. Conversely, in promoter 
peaks more accessible in neurons, we found enrichment of GO terms related to synaptic 
function, including synaptic signaling and neurotransmitter secretion, consistent with biological 
processes central to neuronal function. These results demonstrated that chromatin accessibility 
differences correspond to expected cell-type specific biological processes.  
We also found that differentially accessible peaks were significantly enriched in ATAC-
seq peaks from the relevant in vivo fetal brain laminae (Figure 3.1f) (de la Torre-Ubieta et al., 
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2018). Specifically, peaks more accessible in progenitors were more enriched in peaks with 
higher accessibility in the neural progenitor-enriched germinal zone. Conversely, peaks more 
accessible in neurons were more enriched in peaks more accessible in the neuron-enriched 
cortical plate. These comparisons showed the differentially accessible peaks represent cell-type 
specific active REs and were in strong agreement with biological processes and gene regulatory 
behavior present in in vivo fetal brain tissues.  
To detect TFs involved in neuronal differentiation, we conducted a differential motif 
enrichment analysis to identify predicted TF binding sites more active in either progenitors or 
neurons.  We  detected 62 TFs (FDR < 0.05) with binding sites present more often in progenitor 
peaks than neuron peaks (here, called progenitorTFs), and 208 TF motifs presents more often 
in neuron peaks than progenitor peaks (here, called neuronTFs) (Methods; Supplemental Figure 
3.3b; Supplemental Table 3.2). Within progenitorTFs, we found TFs previously characterized to 
have key roles for neural stem cell renewal and reprogramming, such as SOX2 (Ellis et al., 
2004; D. W. Han et al., 2012), and those known to be required for the maintenance of stem cells 
in cortex, such as NR2F1, ETV5, and SP2 (H. Liang et al., 2013; Y. Liu & Zhang, 2019; Naka et 
al., 2008). Within neuronTFs, NEUROG2 and LMX1A were identified, which are known to drive 
neuronal differentiation (Araújo et al., 2018; Fathi et al., 2015), as well as TFs shown to induce 
neuronal identity from fibroblasts, including ASCL2 and the POU family (Tsunemoto et al., 
2018). NeuronTFs also included CUX1/2, a marker for layer II-III neurons (Cubelos et al., 2015; 
Zimmer et al., 2004) and other laminar markers such as TBR1 and FOXP1. Thus, motifs within 
differentially accessible peaks allow the identification of known TFs that are essential for neural 
progenitor proliferation and differentiation in vivo, providing further support that TF binding within 
chromatin accessibility peaks in this in vitro system reflect the expected in vivo developmental 
processes (Supplemental Figure 3.3c; Supplemental Table 3.2). We also note that we identified 
several TFs that have not been previously associated with neuronal differentiation, such as 
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MEF2A, MIX-A and HOXB5, which may be useful for directed differentiation of human neural 
progenitor cells. 
Chromatin accessibility quantitative trait loci (caQTLs) 
To identify genetic variants that influence chromatin accessibility within two key cell 
types representing longitudinal changes occuring during cortical development, we performed 
caQTL analyses separately for progenitors and neurons (Figure 3.2a; Supplemental Figure 
3.4a-3.4b) using in total 90,227 peaks and 10M genetic variants. Because our sample was 
composed of multiple ancestries (Supplemental Figure 3.4c), we stringently controlled for 
population stratification in our association tests using a linear mixed effects model including a 
kinship matrix as a random effect, and 10 genotype MDS components as fixed effects (H. M. 
Kang et al., 2010; Price et al., 2010; Yang et al., 2014). In addition, we included principal 
components (PCs) across the chromatin accessibility matrix and sorter in neurons as fixed 
effect covariates to reduce the impact of unmeasured technical variation (Pickrell et al., 2010).  
After stringent multiple testing correction (J. R. Davis et al., 2016), we identified 1,839 
progenitor caPeaks (Ndonor=76) and 988 neuron caPeaks (Ndonor=61) at FDR < 5%. These 
caPeaks were significantly enriched in active REs such as enhancers and promoters from fetal 
brains (Supplemental Figure 3.4d), consistent with their expected regulatory function. The most 
significant caSNPs of each caPeaks are most often found near the peaks they are associated 
with (Figure 3.2b), half of the most significant caSNPs are located within ±20kb around peak 
centers. We found that the most significant caSNP or an LD-proxy was located in an annotated 
functional region for over 80% of caPeaks detected (Figure 3.2c; Supplemental Table 3.3). 
These results imply that most genetic variants affect chromatin accessibility by altering the 
sequence (and presumably transcription factor binding sites) at the peak impacted by the 
variant or disrupt chromatin accessibility at distal peaks which have secondary effects on the 
caPeak (Kumasaka et al., 2019).  
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To identify if genetic influences on chromatin accessibility were also associated with 
differences in gene expression, we compared progenitor and neuron caQTLs with eQTLs 
derived from the same cell lines as well as eQTLs derived from the mid-gestation bulk cortical 
wall (Walker et al., 2019). For the most significant caQTL for each caPeak, we estimated the 
posterior probability that the effect is shared between cell-type specific and bulk cortical wall 
eQTLs (m-value > 0.9; Supplemental Table 3.4). Thirty percent of progenitor caQTLs and 
34.9% of neuron caQTLs have shared effects with eQTLs in the same cell types, but a smaller 
proportion of effects are shared with bulk cortical wall eQTLs (Figure 3.2d). Those SNPs with 
shared effects between the caQTLs and eQTLs showed strongly positive correlations in effect 
sizes (r=0.85 for caQTLs and eQTLs in neurons; r=0.84 for caQTLs and eQTLs in progenitors; 
Figure 3.2e). Among shared ca/eSNPs, alleles most often have the same direction of effect on 
both chromatin accessibility and gene expression, indicating that alleles associated with 
increased chromatin accessibility tend to be associated with increased gene expression (Figure 
3.2e).  
We then compared the number and effect size differences between caQTLs and eQTLs. 
First, we subsampled the eQTL dataset to ensure that caQTLs and eQTLs have the same 
sample sizes in order to avoid winner’s curse ((Q. Q. Huang et al., 2018); Methods). In the 
subsampled eQTL datasets, we found comparable proportions of genes associated with genetic 
variation (eGenes) compared to total number of genes measured with caPeaks compared to 
total number of peaks measured: 2.62%/5.81% of peaks measured are neuron/progenitor 
caPeaks; 1.85%/5.70% of genes measured are neuron/progenitor eGenes. We then assessed 
whether genetic variation explained more variation in chromatin accessibility, as compared to 
gene expression in shared caQTLs and eQTLs (Figure 3.2f; Supplemental Figure 3.4e). We 
observed that caQTLs generally explain more variance than eQTLs, implying that caQTL 
studies have higher power than eQTL studies (Gate et al., 2018).  
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Genetic effects on cell-type specific regulatory elements 
By integrating cell-type specific caQTLs and cell-type specific/fetal cortical eQTLs, we 
were able to annotate cell-type specific REs active during human neuronal differentiation and 
identify their cognate genes (Supplemental Table 3.5). We subsequently leveraged these data 
to fine map causal variants within eQTL loci and predict regulatory mechanisms of these non-
coding SNPs associated with both chromatin accessibility and gene expression. Using cell-type 
specific eQTLs, we identified 152 RE-Gene pairs in neurons and 373 RE-Gene pairs in 
progenitors with the caSNPs in the caPeaks. Using the larger sample size of fetal cortical 
eQTLs, we identified 303 RE-Gene pairs in neurons and 282 RE-Gene pairs in progenitors. 
Within these RE-Gene pairs, we found many genes involved in neuronal differentiation such as 
FABP7, VAT1 and FGF1 (L. Feng et al., 1994; Hsu et al., 2009; Loeb-Hennard et al., 2004). We 
also identified RE-gene pairs where the caSNP disrupted TF motifs that have known functions 
in early stem cell and neuronal differentiation (Ballas et al., 2005; Duclot & Kabbaj, 2017; 
Hirayama et al., 2012; Veyrac et al., 2013; Watson et al., 2014). For example, the G allele of 
rs185220 which was associated with increased chromatin accessibility of a caPeak 
(chr5:56,909,141-56,910,860) that overlapped with the SETD9 TSS and was associated with 
increased expression of SETD9 in neurons and progenitors (Figure 3.3a-3.3c). We found that 
rs185220 disrupted several TF motifs. These TFs were ranked by their level of expression in 
progenitors and neurons using fetal brain scRNA-seq data (Polioudakis et al., 2019). We 
prioritized REST due to its high expression in progenitors (Figure 3.3d; logFC=-1.85, FDR = 
2.75e-17 (Aygün et al., 2020)), and evidence of REST binding in ES cells and to a lesser degree 
in neurons differentiated from ES cells (C. A. Davis et al., 2018; ENCODE Project Consortium, 
2012). The G allele of rs185220 led to disruption of the REST motif and increased chromatin 
accessibility, consistent with the function of REST as a repressor (Chong et al., 1995; 
Schoenherr & Anderson, 1995). The predicted regulatory mechanism of rs185220 is that the G 
allele of rs185220 disrupted REST binding, resulting in increased chromatin accessibility and 
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increased expression of SETD9 (Figure 3.3e). As experimental validation of the observed 
caQTL, we found that the G allele of rs185220 increased the activity of this enhancer in 
progenitors relative to the A allele using a luciferase assay (Figure 3.3f). 
As another example of using this dataset to explain the regulatory mechanisms 
underlying an eQTL, we found that the C allele of rs11544037 is associated with increased 
chromatin accessibility of a progenitor caPeak (chr4:158,667,771-158,667,860) located ~5 kb 
upstream from the ETFDH TSS and also associated with increased expression of ETFDH in 
fetal brain (Supplemental Figure 3.5a-3.5c). No caQTL was detected for this SNP in neurons, 
demonstrating cell-type specificity of the effect. rs11544037 disrupted several TF motifs. We 
prioritized RAD21 as the TF with altered binding due to the caSNP based on its high level of 
expression in progenitors (Supplemental Figure 3.5d; logFC=-0.32, FDR=7.55e-18 ((Polioudakis 
et al., 2019),(Aygün et al., 2020))). In contrast with the previous example, the C allele of 
rs11544037 matched the motif of RAD21 Supplemental Figure 3.5e) and was associated with 
increased chromatin accessibility of this enhancer in progenitors and increased expression of 
EFTDH. Experimental validation via a luciferase reporter assay showed a consistent result with 
the caQTL for this enhancer (Supplemental Figure 3.5f).  
In a final example of a regulatory mechanism underlying a cell-type specific eQTL, we 
found the C allele of rs11960262 associated with increased chromatin accessibility of a caPeak 
(chr5:142,684,441-142,686,700) located in the intron of the gene FGF1 and also associated 
with increased expression of FGF1 specifically in progenitors (Supplemental Figure 3.5g-3.5i). 
The rs11960262 disrupted EGR1 and EGR4 motifs, but we prioritized EGR1 due to its high 
expression in progenitors (Supplemental Figure 3.5j). The C allele of rs11960262 matched the 
motif of EGR1 (Supplemental Figure 3.5k), which suggests that EGR1 binding was associated 




Allele Specific Chromatin Accessibility 
We next performed an analysis to detect ASCA for each heterozygous SNP located 
within accessible peaks (Methods). ASCA analysis contrasts accessibility between two alleles 
within an individual heterozygous at a given SNP, so it is not susceptible to cross-individual 
confounding factors, such as population structure (Pastinen, 2010). In total, we identified 1,602 
significant (FDR < 0.05) progenitor ASCA and 3,288 significant neuron ASCA (Supplemental 
Table 3.6). To determine if caQTLs also show ASCA, we filtered to keep significant caQTLs 
(non-clumped, FDR < 0.05) using the same heterozygous donor and read level criteria 
described for ASCA, observing that 90.1% of filtered neuron caQTLs were shared with neuron 
ASCA (Fisher’s test: OR=51.48, p-value=1.32e-228) and 86.9% of filtered progenitor caQTLs 
were shared with progenitor ASCA (Fisher’s test: OR=45.54, p-value=1.37e-239). This 
demonstrates extremely high overlap between caQTLs and ASCA (Figure 3.4a), which indicates 
minimal influence of cross-individual confounding effects, such as population stratification, on 
the caQTL results. Similarly, for all filtered caQTLs and significant ASCA in Figure 3.4a, we 
found high correlations of effect sizes between caQTLs and ASCA (r=0.61 for neurons; r=0.69 
for progenitors), indicating a shared direction and degree of effect (Figure 3.4b). Subsetting to 
only significant caQTLs and ASCAs, the correlation of effect sizes is greater than 0.9 for both 
neurons and progenitors (Figure 3.4b), again providing alternative validation of the discovered 
caQTLs. The alternative allele showed a slight bias, even after mapping accounting for 
reference mapping bias, for a higher correlation with increasing chromatin accessibility from the 
reference allele. The log2(ALT/REF) of neuron ASCA are 53.4% positive (sign test p=0.034); 
the log2(ALT/REF) of progenitor ASCA are 52.5% positive (sign test p=0.121).  
However, we also detected significant ASCAs that were not significant caQTLs (Figure 
3.4b). These variants were found in larger peaks than those detected in both caQTL and ASCA 
(Supplemental Figure 3.6a). These ASCA-but-not-caQTL variants likely have an effect on the 
accessibility of a sub-region of the larger active RE. We posit that they are more detectable 
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using ASCA because only reads containing the variant at the location where accessibility is 
affected are tested for association, whereas they are not detectable in caQTLs, which integrate 
reads across the entire region. For example, we detected ASCA at SNP rs62332390, which was 
associated with differences in chromatin accessibility of a sub-peak, but was not a caQTL for 
the called larger peak where it resides (4,689 bp; Supplemental Figure 3.6b). Other ASCA-but-
not-caQTL sites were presumably due to lower power for caQTL detection (Supplemental 
Figure 3.6c). 
We identified several loci that shared caQTLs, ASCA, and eQTLs. For example, the 
previously described SETD9 locus also demonstrated strong ASCA at rs185220 in both neurons 
and progenitors (Supplemental Figure 3.6d). We were also interested in FABP7 (also known as 
BLBP), which is a marker for radial glia that plays an important role in the establishment of the 
radial glial fibers spanning the cortical anlage during cortical development (L. Feng et al., 1994) 
(Figure 3.4c). The C allele of rs144376334 was associated with increased chromatin 
accessibility of the caPeak (chr6:122,832,401-122,834,160) in both progenitors and neurons 
and increased gene expression of FABP7 (Figure 3.4d). The C allele of rs144376334 also 
showed increased allele-specific chromatin accessibility in both progenitors and neurons (Figure 
3.4e). rs144376334 disrupted several TF motifs that may be driving the effect in both cell types, 
and we highlight FOS::JUN due to its higher expression in progenitors using scRNA-seq data 
(Polioudakis et al., 2019); Figure 3.4e) and cell-type specific RNA-seq data (logFC = -1.22, FDR 
= 1.816794e-11) (Aygün et al., 2020), as well as the known function of this gene in progenitors. 
The motif disrupting allele was associated with decreased chromatin accessibility, consistent 
with activating REs (Figure 3.4g). Based on these data, we suggest the potential regulatory 
mechanism underlying this genetic locus in progenitors is that the genetic variation disrupts JUN 
binding to a distal RE leading to decreased expression of FABP7. 
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Genetic effects on chromatin accessibility are cell-type specific 
To determine the cell-type specificity of caQTLs between progenitors and neurons, we 
quantified the degree of overlap between cell types. For both caQTL and eQTL, we estimated 
the posterior probability that the allelic effect is shared between cell types (m-value > 0.9). 
caQTLs showed a lower proportion of effect sharing between neurons and progenitors (45.6% 
and 41.0%) than eQTLs (78.0% and 56.7%) (Figure 3.5a). We found the estimated proportion of 
true alternative hypotheses that the variant is associated with the trait (π1) of the most 
significant neuron/progenitor caSNP-caPeak pairs in progenitors/neurons is 0.73/0.70; however, 
the π1 of the most significant neuron/progenitor eSNP-eGene pairs in progenitors/neurons is 
0.92/0.77, providing additional support that caQTLs have higher cell-type specificity than 
eQTLs. To determine if genetic variation impacts the same peaks in both progenitors and 
neurons, we quantified the degree of overlap in caPeaks. We found 19%/35% of 
progenitor/neuron caPeaks overlapped with neuron/progenitor caPeaks (Figure 3.5b). For 
ASCA, we found 24%/12% of progenitor/neuron ASCA are shared between cell types, which 
was in agreement with the cell-type specificity observed in caQTLs. These results suggest that 
genetic variants often impact chromatin accessibility only within specific cell-types.  
To further characterize the cell-type specificity of caQTLs, we assessed the differential 
accessibility of progenitor and neuron caPeaks (Figure 3.5c). We found 71.0% of progenitor 
caPeaks were more accessible in progenitors as compared to neurons (LFC > 0). Similarly, 
69.8% neuron caPeaks were more accessible in neurons as compared to progenitors (LFC < 0). 
This implies that a RE must be accessible to or bound by DNA-binding proteins within a specific 
cell-type in order to observe genetic effects on that RE. We next characterized the location of 
caPeaks relative to the nearest promoter (Figure 3.5d). We found there was a higher 
percentage of cell-type specific caPeaks that were distal to promoters than shared caPeaks. 
This result indicates cell-type specific caQTLs were more likely to affect the chromatin 
accessibility of distal REs, which is consistent with observations that distal REs like enhancers 
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have higher cell-type specificity than promoters (Heinz et al., 2015; Roadmap Epigenomics 
Consortium et al., 2015).  
To determine the direction and magnitude of the effect of a genetic variant on chromatin 
accessibility between cell types, we related the effect sizes of caQTLs or eQTLs in one cell-type 
to the other. We found that caQTLs showed a lower correlation between neurons and 
progenitors (r=0.73 and r=0.70) as compared to eQTLs (r=0.81 and r=0.81) (Figure 3.5e-3.5f; p 
value < 2.2e-16 in neurons and progenitors(Diedenhofen & Musch, 2015)), which is consistent 
with the observation that caQTLs showed a lower proportion of shared effects between neurons 
and progenitors than eQTLs (Figure 3.5a). Together, these results suggested that caQTLs have 
higher cell-type specificity than eQTLs, within the cell types tested here.  
Comparison to adult dorsolateral prefrontal cortex (DLPFC) caQTLs  
Previous work identified common variant associations with chromatin accessibility in 
adult post-mortem DLPFC using a sample of 272 individuals (Bryois et al., 2018). We tested 
whether the caQTLs identified in our current work, modeling a prenatal time period, were also 
present in the adult cortex. We found 56% of adult peaks are shared in neurons and progenitors 
(average read counts > 5; Supplemental Figure 3.7a-3.7b). We re-mapped caQTLs in neurons 
and progenitors using shared peaks and genetic variants with the adult data. We did not find 
any significant neuron/progenitor caQTLs shared with significant caQTLs in adult cortex. For the 
27 significant neuron caQTLs, we found the correlation (r=0.61) of effect sizes with adult 
caQTLs are higher than the correlation (r=0.34) in 35 significant progenitor caQTLs 
(Supplemental Figure 3.7c), which may be expected given that progenitors are not present in 
the adult cortex. Together, these results indicate that caQTLs have high temporal specificity, as 
well as cell-type specificity.  
Prediction of disrupted transcription factor (TF) binding due to genetic variation 
One favored model of how genetic variation leads to changes in chromatin accessibility 
is that SNPs disrupt TF motifs, decreasing the probability of TF binding to chromatin, and 
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resulting in decreased chromatin accessibility (Behera et al., 2018; Gate et al., 2018). To 
determine which TF motifs are disrupted by cell-type specific caSNPs, we mapped known TF 
motifs from JASPAR2016 (Mathelier et al., 2016) to the sequence surrounding the neuron-
specific/progenitor-specific caSNPs and determined if an allele at the caSNP sufficiently 
decreases the relative entropy of TF binding using the position possibility matrix (PPM; 
Methods; Supplemental Table 3.7; (Coetzee et al., 2015)). Most often, an individual caSNP only 
disrupts one TF motif (Figure 3.6a). However, given the ubiquitousness of motifs in the genome, 
some caSNPs can disrupt motifs of as many as 35 TFs (Figure 3.6a). Conversely, we found one 
motif could be disrupted by many genetic variants in different peaks (the SOX8 motif was 
disrupted by 15 progenitor caSNPs). To identify those TFs whose motif is often disrupted 
leading to a caQTL within each cell-type, we performed an enrichment analysis on TF motifs 
disrupted by caSNPs within peaks, then filtered the TF motifs by differential expression in the 
specific cell type. In progenitors, we found enriched TF motifs such as REST and SOX11 which 
are well known to contribute to neurogenesis (Bergsland et al., 2006; Chong et al., 1995). In 
neurons, we found enriched TF motifs such as RARb which is shown to be involved in prefrontal 
synaptogenesis and axon development (Shibata et al., n.d.) (Figure 3.6b). These results 
suggest that the TFs whose motifs are disrupted by caSNPs are involved in neuronal 
differentiation, indicating that the genetic variants that impact the activity of REs by disrupting 
the binding of TFs play functional roles during these biological processes.  
We next tested the impact of the TF motif-disrupting alleles on chromatin accessibility 
using all available TF motifs where we observed at least 5 motif disrupting caSNPs. Among 532 
tested TFs in progenitors and 514 tested TFs in neurons, we found that motif disrupting alleles 
often led to decreased accessibility for 40 (72.7% of significant TFs) TFs in progenitors and 44 
(97.8% of significant TFs) TFs in neurons (Figure 3.6c-3.6d), such as the motif of POU3F2 
(known as BRN2) in progenitors and ASCL2 in neurons, which are both involved in 
neurogenesis (X. He et al., 1989; Tsunemoto et al., 2018) (Figure 3.6e). Conversely, we found 
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the caSNP motif-disrupting allele was associated with increased chromatin accessibility at the 
motif of ZEB1, a known transcriptional repressor (Figure 3.6f) (Huanhuan Wang et al., 2019). 
These results suggest that binding of transcriptional activators was associated with increased 
chromatin accessibility. However, binding of transcriptional repressors was associated with 
decreased chromatin accessibility. 
Regulatory mechanisms underlying GWAS loci 
To investigate if genetic variants associated with common neuropsychiatric disorders 
and brain structure traits are enriched in differentially accessible peaks during cortical 
neurogenesis, we calculated partitioned heritability enrichment using LD score regression 
(Bulik-Sullivan et al., 2015; Finucane, Bulik-Sullivan, Gusev, Trynka, Reshef, Loh, Anttilla, Xu, 
Zang, Farh, Ripke, Day, Consortium, et al., 2015) (Figure 3.7a-3.7b). Similar to a previous study 
in mid-gestation fetal brain (de la Torre-Ubieta et al., 2018), we found cell-type specific 
enrichments for neuropsychiatric disorders and associated behaviors in regions of accessible 
chromatin. Genetic variants associated with several childhood or adult onset neuropsychiatric 
disorders or traits, including ASD, schizophrenia, ADHD, major depressive disorder (MDD), 
neuroticism and depressive symptoms, showed significant partitioned heritability enrichment in 
progenitor peaks. With the exception of schizophrenia, these disorders did not show significant 
enrichment in neuron peaks. We observed partitioned heritability enrichment for both 
intelligence and educational attainment within peaks differentially accessible in both cell types. 
As a negative control, we did not observe enrichment of inflammatory bowel disease (IBD) 
heritability in differentially accessible peaks, as expected. These results are consistent with the 
model (de la Torre-Ubieta et al., 2018; Walker et al., 2019) that genetic variants alter the 
function of REs during cortical neurogenesis, which then leads to risk for neuropsychiatric 
disorders or related traits in childhood or adulthood.  
We also found genetic variants associated with the global surface area of the cortex 
showed significant partitioned heritability enrichment in progenitor peaks, as well as the surface 
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area of cortical subregions including caudal anterior cingulate, entorhinal, lateral occipital, 
lingual and pericalcarine (Grasby et al., 2018) (Figure 3.7b). Genetic variants associated with 
the thickness of the entorhinal cortex, but not average thickness across the entire cortex, also 
showed significant partitioned heritability enrichment in progenitor peaks. These results are 
consistent with the radial unit hypothesis, which posits that expansion of the neural progenitor 
pool in prenatal development leads to alterations in adult cortical surface area (Rakic, 1988). 
To study the cell-type specific gene-regulatory impact of specific genetic variants 
associated with these neuropsychiatric disorders and brain structure traits, we performed a 
colocalization analysis of caQTLs in progenitors and neurons with existing GWAS data 
(Supplemental Table 3.8). We identified putatively co-localized signals (pairwise LD r2 > 0.8 
between the GWAS index and caQTL index) and then performed a conditional analysis to verify 
that the two variants mark the same locus (Methods). We found co-localized loci in several 
neuropsychiatric disorders, including schizophrenia, MDD, neuroticism and bipolar disorder, as 
well as IQ and educational attainment (Figure 3.7c). We also found co-localizations with global 
surface area and other brain structure associated loci. We found additional ASCA sites located 
within GWAS loci (Supplemental Figure 3.8a; Supplemental Table 3.8). These results suggest 
that SNPs impact risk for brain-relevant traits and disorders by regulating the activity of REs in 
these two cell types during mid-fetal brain development, and provide a framework for exploring 
the mechanistic bases for these specific disease-associated risk loci. 
We next investigated regulatory mechanisms underlying co-localized loci using cell-type 
specific caQTLs. Combining fetal cortical/cell-type specific eQTL data, we found a co-localized 
locus across progenitor specific caQTLs, fetal cortical eQTLs and MDD GWAS (Figure 3.7d). 
We found more than 30 SNPs in high LD with an MDD GWAS index SNP (rs1950826). Eight of 
these variants were located in a caPeak (chr14:41,604,471-41,610,540). We prioritized one 
putatively causal SNP among those 8 by testing for ASCA, finding that the A allele of the caSNP 
rs1950834 (protective allele for MDD), was associated with decreased accessibility of this 
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caPeak in progenitors (Figure 3.7e-3.7f and 3.7h), which is consistent with luciferase reporter 
assay in previous work (S. Li et al., 2020). We also found rs1950834 was an eSNP, of which the 
A allele was associated with decreased expression of lncRNA AL121821.1 
(ENSG00000258636) in fetal cortex and progenitors (Figure 3.7g). After conditioning on the 
MDD index SNP, rs1950826, the caQTL was no longer significant, indicative of co-localization 
(Figure 3.7d). We found evidence to support that this SNP disrupts the binding of ETV1 (Figure 
3.7i; Methods; (Polioudakis et al., 2019)). This suggests that the protective mechanism of this 
locus for MDD is via the protective allele at the caSNP disrupting binding of ETV1 at an RE in 
progenitors, decreasing chromatin accessibility of this caPeak, and resulting in decreased 
expression of lncRNA AL121821.1.  
As an additional example, we detected a co-localized locus between a neuron specific 
caQTL and schizophrenia GWAS (Supplemental Figure 3.8b). We found the C allele 
(schizophrenia protective allele) of the caSNP, rs9930307, was associated with decreased 
chromatin accessibility of a caPeak (chr16: 9,805,221-9,805,420) in neurons (Supplemental 
Figure 3.8c). This caSNP was also a neuron-specific ASCA site, providing further evidence of 
this allele’s impact on chromatin accessibility (Supplemental Figure 3.8c). After conditioning on 
the schizophrenia index SNP (rs7191183) in the caQTL analysis, the caSNP was no longer 
significant (Supplemental Figure 3.8b). The TF motif of TP53 was disrupted by this caSNP 
(Supplemental Figure 3.8d-3.8e). Using a luciferase reporter assay, we found the C allele 
decreased the activity of this enhancer which is in agreement with the caQTL result 
(Supplemental Figure 3.8f). 
3.3 Discussion 
Our caQTL analysis identified regulatory mechanisms underlying risk variants for 
neuropsychiatric disorders, cortical structure and other brain-relevant traits. The function of 
genetic variants associated with these traits are often difficult to interpret because most of these 
variants are mapped to non-coding regions in the genome (Tak & Farnham, 2015). Currently, 
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the function of individual non-coding brain-relevant risk loci is commonly understood through co-
localization with eQTLs in adult post-mortem brain tissue or chromatin interaction (D. Wang et 
al., 2018; Won et al., 2016). Our study and dataset is able to complement this previous work in 
several ways: (1) caQTL analysis allows fine mapping of causal variants within correlated LD-
blocks by identifying putatively causal variants within peaks; (2) cell-type specific caQTL 
analysis can prioritize cell-types mediating the risk for neuropsychiatric illness because genetic 
effects on REs are highly specific; (3) most previous eQTL studies have been performed in 
post-mortem adult brain cortex (Dobbyn et al., 2018; GTEx Consortium et al., 2017; D. Wang et 
al., 2018), but cell-types contributing to the heritability for multiple disorders and traits are not 
present at this developmental stage suggesting that temporal specificity matters for 
understanding risk for these disorders (Figure 3.7;  (de la Torre-Ubieta et al., 2018)); and (4) 
integration of caQTL, eQTL, and brain-trait GWAS allows a more complete understanding of the 
gene regulatory mechanism leading to risk for neuropsychiatric disorders, where non-coding 
genetic variants disrupt TF binding to REs, affecting chromatin accessibility, influencing 
expression of genes, leading to downstream risk for neuropsychiatric disorders. While we 
prioritized TFs driving the regulatory effects based on motif disruption and expression in the cell-
type of interest, further experimental validation using complementary techniques (e.g. ChIP-seq) 
is necessary to determine if the caSNP does in fact disrupt binding of the prioritized TF. Our 
study provides a resource to understand the impact of genetic variation on gene regulation 
during human cortical neurogenesis and provides an additional layer of information to explain 
the function of common variants associated with risk for neuropsychiatric illness and brain-
related traits. 
We found schizophrenia risk variants are enriched in REs of progenitors (Figure 3.7a), 
consistent with previous post-mortem human studies (M. Li et al., 2018), but contrary to a 
mouse gene expression study that found enrichments in neuronal but not progenitor cell 
types(Skene et al., 2018). Given that the mouse study may miss human specific REs and 
 40 
assigns variants to genes by proximity, we believe that our findings in combination with previous 
literature suggest that genetic alterations in both human progenitor and adult neuronal REs 
contribute to risk for schizophrenia. 
There are several existing methods to map REs in the non-coding genome to the genes 
they regulate, including chromatin interaction, peak-peak correlation, and high-throughput 
CRISPRi screens (Corces et al., 2018; Fulco et al., 2019; Won et al., 2016). Here, we integrate 
caQTL and eQTL studies as an additional method to both identify the genes regulated by REs 
and to propose causal variants altering the function of these REs. This is complementary to 
chromatin interaction assays, such as Hi-C, which demonstrate physical interaction with a 
promoter region, but are not always indicative of regulation (Alexander et al., 2019; Benabdallah 
et al., 2019). caQTL and eQTL studies require genetic variation to be present in a population in 
order to detect their impact. Strong negative selection for genetic variation within REs of genes 
critical to life may lead to the absence of these variants in the population sampled. Therefore, 
RE-gene mapping would not be possible for these REs through the integration of caQTL/eQTL 
datasets. However, for the class of common genetic variation, which is demonstrated to have a 
large impact on risk for neuropsychiatric disorders and brain traits in aggregate (Sullivan & 
Geschwind, 2019), this method is useful for both fine mapping and identifying genes regulated 
by REs. 
We provide evidence to support that caQTLs both have higher effect sizes and more 
cell-type specificity than eQTLs in the cell types we measured in this study. This suggests that 
there are a limited number of mechanisms whereby sequence variation impacts chromatin 
accessibility (caQTL), including TF binding to DNA, whereas there are considerably more 
mechanisms by which sequence variation can impact transcript levels (eQTL), such as altering 
TF binding, impacting methylation, or altering miRNA binding sites (Bell et al., 2011; Chen & 
Rajewsky, 2006; Gaffney et al., 2012). This also suggests that caQTL analyses will identify 
more genetic variants involved in gene regulation than eQTLs given a limited sample size. 
 41 
Future cell-type specific caQTL analyses will be better powered to identify cell-types involved in 
the mechanism of GWAS risk variants. However, because our comparison was conducted 
between only two cell types, other cell-type specific caQTL and eQTL studies will be necessary 
to confirm the higher cell-type specificity of caQTLs more broadly.  
We found that genetic variants associated with differences in chromatin accessibility 
often disrupted the motifs of TFs involved in neurogenesis, which supports the hypothesis that 
genetic variation affects chromatin accessibility by disrupting the binding of TFs (Behera et al., 
2018). Moreover, we identified which TF motifs were disrupted by genetic variants and found 
that disruption of motif binding generally leads to decreased chromatin accessibility, with the 
exception of repressive TFs. These results support a model where chromatin accessibility is 
increased when activating TFs are bound (Janicki et al., 2004). Our results also support a model 
where binding of repressive TFs condenses chromatin in REs (Kornberg & Lorch, 1999).  
caQTL analysis is able to identify genetic variants associated with REs and to prioritize 
causal variants, but cannot be used directly to predict the genes regulated by these elements. 
Most caQTLs did not result in changes in gene expression in either these cell types or in bulk 
fetal cortical tissue. Previous work has suggested that the motif-disrupting alleles do not result in 
changes to gene expression without the presence of additional transcription factors binding to 
the same RE (Alasoo et al., 2018). These additional transcription factors may be translocated to 
the nucleus in response to an external stimulus. caQTLs may therefore be more likely to co-
localize with risk loci even in the absence of external stimuli (context-independence), whereas 
eQTLs would require additional stimuli (context-dependence). This also suggests that future 
work identifying caQTL/eQTLs in response to environmental stimuli relevant to neural 
proliferation, differentiation, or function will be especially useful to interpret GWAS risk loci, 






Figure 3.1: Profiling genome-wide chromatin accessibility in progenitors and neurons.(a) Schematic 
cartoon of experimental design. SOX2 and PAX6 immunolabeled neural progenitors (left), showing over 
90% of cells were radial glia. EGFP labeled differentiated neurons (right), showing expected neuronal 
morphology.(b) Percentage of accessible peak base pairs (bp) detected in these cultures overlapped with 
epigenetically annotated regulatory elements from multiple tissues. From top to bottom, tissues ordered 
by bp percentage overlap with enhancers and promoters. (c) PCA plot of ATAC-seq read count after 
batch effect correction colored by cell types, showing two separate clusters for progenitors and 
neurons.(d) MA plot for differentially accessible peaks between progenitors and neurons. (e)ATAC-seq 
coverage plot (average normalized read counts) for promoters of neuron expressed gene SYT13, 
showing higher accessibility in neurons than progenitors (LFC=-1.16, FDR=3.28e-35). ATAC-seq 
coverage plot (average normalized read counts) for promoter of progenitor expressed gene EMX2, 
showing higher accessibility in progenitors than neurons (LFC=1.62, FDR=1.12e-32). (f) Enrichment of 
differentially accessible peaks identified here with differentially accessible peaks from fetal brain tissue 
(de la Torre-Ubieta et al., 2018). GZ: neural progenitor-enriched region encompassing the ventricular 
zone (VZ), subventricular zone (SVZ), and intermediate zone (IZ); CP: the neuron-enriched region 





Figure 3.2: Chromatin accessibility quantitative trait loci (caQTL) in progenitors and neurons. (a) caQTL 
schematic. (b) Number of the most significant caSNPs relative to the distance from the center of the 
caPeaks (left: neuron caQTLs; right: progenitor caQTLs). (c) Numbers of caQTLs in different functional 
categories.(d) Schematic cartoon of fetal cortical(Walker et al., 2019) and cell-type specific eQTLs (Aygün 
et al., 2020) (Walker et al., 2019)(Left). Percentage of neuron/progenitor caQTLs with shared effects in 
fetal cortical and cell-type specific. (e) Correlation of effect sizes between shared the most significant 
caQTLs and eQTLs in neurons (left) and progenitors (right). (f) Comparison of percent variance explained 
(r2) for shared caQTLs and eQTLs (subset to the same sample size) in neurons and progenitors. We 
found 500 (e)caSNP-caPeak-eGene combinations in neurons and 1,025 (e)caSNP-caPeak-eGene 
combinations in progenitors. We observed higher percent variance explained for caQTLs than eQTLs in 




Figure 3.3: Fine-mapping and regulatory mechanism underlying eQTLs. (a) Co-localization of caQTL and 
eQTL in progenitors and neurons for SETD9. ChIP-seq data of REST binding in H1 cells and neurons 
differentiated from H1 cells (C. A. Davis et al., 2018; ENCODE Project Consortium, 2012). (b) The 
association between rs185220 and chromatin accessibility of the labeled peak in progenitors (top) and 
neurons (bottom). The whiskers extend up to 1.5 times the interquartile range from the top (bottom) of the 
box to the furthest datum within that distance. (c) The association between rs185220 and expression of 
SETD9 in mid-gestation cortex (top), progenitors (middle) and neurons (bottom). (d) The expression of 
TFs in which motifs are disrupted by rs185220. vRG: ventricular Radial Glia; oRG: outer Radial Glia; PgS: 
Cycling progenitors (S phase); PgG2M: Cycling progenitors (G2/M phase); IP: Intermediate progenitors; 
ExN: Migrating excitatory; ExM: Maturing excitatory; ExM-U: Maturing excitatory upper enriched; ExDp1: 
Excitatory deep layer 1; ExDp2: Excitatory deep layer 2. (e) The motif Logo of REST, where the red box 
shows the position disrupted by rs185220. Schematic cartoon of proposed mechanism for rs185220 
regulating chromatin accessibility and gene expression. (f) The box plot for luciferase signal for alleles of 




Figure 3.4: Allele Specific Chromatin Accessibility (ASCA).(a) Numbers of shared/non-shared significant 
caQTLs and significant ASCA in neurons (left) and progenitors (right). (b) Correlation of effect sizes for 
caQTL and ASCA from (A) neurons (top) and progenitors (bottom). (c) Co-localization of caQTL and 
ASCA in progenitors and neurons as well as mid-gestation cortical eQTL for FABP7. (d) Association 
between rs144376334 and expression of FABP7 in mid-gestation cortex (left), chromatin accessibility of 
the labeled peak in progenitors (middle) and neurons (right). (e) ASCA detected at rs144376334 in 
progenitors (left) and neurons (right). (f) The expression of TFs where motifs are disrupted by 




Figure 3.5: Cell-type specificity of caQTLs. (a) Percentage of caQTLs (left)/eQTLs (right) with shared 
effects in neurons and progenitors. (b) Numbers of overlapped/non-overlapped caPeaks (left) and ASCA 
(right) between neurons and progenitors. (c) Differential accessibility of progenitor caPeaks (left) and 
neuron caPeaks (right). (d) Numbers and percentage of caPeaks distal to promoters or proximal to 
promoters for neuron-specific caQTLs, progenitor-specific caQTLs and shared caQTLs between neurons 
and progenitors. (e) Correlations of effect sizes of caQTLs between neurons and progenitors (left: 
progenitor caQTLs vs. the same caSNP-caPeak pairs in neurons; right: neuron caQTLs vs. the same 
caSNP-caPeak pairs in progenitors). (f) Correlations of effect sizes of eQTLs between neurons and 
progenitors (left: progenitor eQTLs vs. the same eSNP-eGene pairs in neurons; right: neuron eQTLs vs. 





Figure 3.6: Prediction of disrupted transcription factor (TF) binding due to genetic variation. (a) Numbers 
of TFs where motifs were disrupted by progenitor-specific caSNPs (top) and neuron-specific caSNPs 
(bottom). (b) Enrichment of caSNP-disrupted motifs in accessible peaks in progenitors (top) or in neurons 
(bottom). (c) Schematic of TF motifs disrupted by caSNPs associated with decreased/increased 
chromatin accessibility. (d) Numbers and percentage of TFs where the motif-disrupting allele was 
associated with increased/decreased chromatin accessibility in progenitors (left) and neurons (right). For 
most TFs, the motif-disrupting allele was associated with decreased chromatin accessibility in progenitors 
and neurons. (e) Examples of TF motifs disrupted by caSNPs associated with decreased chromatin 
accessibility in progenitors (POU3F2; left) and neurons (ASCL2; right). (f) Disrupting ZEB1 (a 
transcriptional repressor) binding motif was associated with increased chromatin accessibility in 





Figure 3.7: Cell-type specific caQTLs lead to regulatory mechanisms underlying GWAS loci. (a) 
Partitioned heritability enrichment (* signifies FDR < 0.05). (b) Partitioned heritability enrichment 
demonstrated a significant (FDR < 0.05) enrichment of heritability for surface area of the full cortex, 
caudal anterior cingulate, entorhinal, lateral occipital, lingual and pericalcarine cortex and the thickness of 
entorhinal cortex within progenitor peaks. (c) Numbers of colocalizations between caQTLs and GWAS 
loci. (d) A colocalized locus between progenitor-specific caQTL and MDD GWAS. (e) Association 
between rs1950834 and chromatin accessibility of the labeled peak in progenitors. (f) ASCA of rs1950834 
in progenitors. (g) Association between rs1950834 and expression of lncRNA AL12182.1 in fetal brain 
(left) and progenitors (right). (h) Zoomed in plot of caPeaks colored by genotype at rs1950834. (i) The 





Supplemental Figure 3.1: Flowchart for cell culture and pre-processing of ATAC-seq data. (a) Flowchart 
of cell culture for 17 rounds. (b) The FACS gates for sorting EGFP+ neurons. (c) Images of 
immunofluorescence for cell markers in progenitor cultures. (d) Images of immunofluorescence for cell 
markers in 8-week differentiated cultures. (e) Box plot for total sequence depth (forward reads and 
reverse reads), unique read number (forward reads and reverse reads), duplicate rate, mitochondrial 
duplicate rate, TSS enrichment and the fraction of reads in called peak regions (FRiP score) in neurons 




Supplemental Figure 3.2: ATAC-seq data QC. (a) Peak calling versus library sequencing depth. We 
observed a slower rise in the number of new peaks called after 15 millions filtered read pairs in both 
neurons and progenitors. This indicates a reasonable balance between read depth and number of new 
peaks called using an average of 14 million read pairs after filtering acquired in our samples. (b) Insert 
size histograms from 3 randomly selected neuron samples and progenitor samples, showing the 
expected phasing pattern of transposase insertion between nucleosomes. (c) PCA plot for ATAC-seq 
data before batch correction (left) and after batch correction (right), colored by sorter. We corrected 
normalized reads within ATAC-seq peaks in neurons by sorter locations. Then, we corrected normalized 
reads within ATAC-seq peaks in neurons and progenitors by cell culture round. (d) Correlations of batch 
corrected normalized reads across donors and within donors in neurons and progenitors. Correlations 
within donors was significantly higher than correlations across donors in progenitor. Correlations within 
donors were higher than correlations across donors in neurons, but not significant (p=0.07), likely due to 
the fewer number of replicates (n=4). (e) Correlations between PC1 to PC10 from normalized reads 
(before and after batch correction) in neurons with known technical and biological factors. (f) Correlations 
between PC1 to PC10 from batch correction normalized reads (before and after batch correction) in 




Supplemental Figure 3.3: Annotating differentially accessible peaks during neuronal differentiation. (a) 
Gene ontology (GO) enrichment of differentially accessible peaks at the TSS. Progenitor peaks (left) and 
neuron peaks (right) showed enrichment for GO terms related to proliferation and differentiation, as 
expected. (b) TFs with significantly differentially enriched conserved binding sites in differentially 
accessible peaks. The statistical test identifies TFs likely involved in neural progenitor proliferation and 
maintenance (progenitorTFs; top) or neurogenesis and maturation (neuronTFs; bottom). The top 30 
significantly enriched TFs were shown in this figure. (c) Schematic of known functions for selected 





Supplemental Figure 3.4: Features of caQTLs. (a) Flowchart for caQTL data analysis. (b) PCA plot for 
ATAC-seq data on sex chromosomes (chrX and chrY), colored by sex from genotype data, showing sex 
could be called using ATAC-seq data. (c) MDS plot for genotype data of HapMap3 and donors in this 
study, colored by populations from HapMap3 data. ASW: African ancestry in Southwest USA; CEU: Utah 
residents with Northern and Western European ancestry from the CEPH collection; CHB: Han Chinese in 
Beijing, China; CHD: Chinese in Metropolitan Denver, Colorado; GIH: Gujarati Indians in Houston, Texas; 
JPT: Japanese in Tokyo, Japan; LWK: Luhya in Webuye, Kenya; MEX: Mexican ancestry in Los Angeles, 
California; MKK: Maasai in Kinyawa, Kenya; TSI: Toscans in Italy; YRI: Yoruba in Ibadan, Nigeria. (d) 
Neuron and progenitor caPeaks enrichment at epigenetically annotated regulatory elements from fetal 
brain (Epigenetics Roadmap ID = E081). (e) Comparison of percent variance explained (r2) for shared 





Supplemental Figure 3.5: Examples of fine-mapping and regulatory mechanisms underlying eQTLs. (a) 
Co-localization of a progenitor-specific caQTL and fetal cortical eQTL for ETFDH. (b) The association 
between rs11544037 and chromatin accessibility of the labeled peak. (c) The association between 
rs11544037 and expression of ETFDH in bulk fetal cortex. (d) The expression of TFs in which motifs are 
disrupted by rs11544037. (e) The motif Logo of RAD21, where the red box shows the position disrupted 
by rs11544037. Schematic cartoon of mechanisms for rs11544037 regulating chromatin accessibility and 
gene expression. (f) The box plot for luciferase signal for alleles of rs11544037 in progenitors (N=8). P 
value is from paired t-test. (g) Co-localization of a progenitor-specific caQTL and eQTL for FGF1. (h) The 
association between rs11960262 and chromatin accessibility of the labeled peak. (i) The association 
between rs11960262 and expression of ETFDH in progenitors. (j) The expression of TFs in which motifs 
are disrupted by rs11960262. (k) The motif Logo of EGR1, where the red box shows the position 
disrupted by rs11960262. Schematic cartoon of mechanisms for rs11960262 regulating chromatin 




Supplemental Figure 3.6: Features of ASCA. (a) Density plot for caPeak length from shared caQTLs and 
ASCA and from peaks only significant in ASCA in neurons (top) and progenitors (bottom). caPeak length 
from only significant in ASCA was significantly larger than caPeak length from shared significant caQTLs 
and ASCA. (b) The neuron ASCA (caSNP: rs62332390; caPeak: chr4:148,441,611-148,46,300) is not a 
significant caQTL in neurons because the caPeak was very wide (4,689bp) and only the region near the 
ASCA SNP shows an association with genotype. (c) The neuron ASCA (caSNP:rs77191441; 
caPeak:chr5:116,571,961-116,576,710) is not a significant caQTL in progenitors due to low minor allele 
frequency leading to less power to detect a caQTL. (d) ASCA between rs185220 (see Figure 3.3) and 




Supplemental Figure 3.7: Comparison to adult dorsolateral prefrontal cortex (DLPFC) caQTLs and TF 
motif family disrupted by caSNPs. (a) Shared accessible peaks overlap at epigenetically annotated 
regulatory elements from different tissues. Accessible peak bp percentage overlapped with epigenetically 
annotated regulatory elements. From left to right, tissues ordered by bp percentage overlap with 
enhancers and promoters. Shared peaks overlap with both adult and fetal regulatory elements. (b) PCA 
plot for read counts from shared peaks in adult DLPFC, neurons and progenitors. (c) Correlations of 
effect sizes for significant neuron caQTLs and the same SNP-Peak pairs in adult DLPFC (top). 





Supplemental Figure 3.8:  An example of a cell-type specific caQTL leading to regulatory mechanisms 
underlying GWAS loci. (a) Numbers of colocalizations between ASCA and GWAS loci. (b) The neuron-
specific significant caQTL (caSNP: rs9930307; caPeak: chr16: 9,805,221-9,805,420) co-localized with 
schizophrenia GWAS locus (Index SNP: rs7191183). (c) Box plot for the caQTL (left) and ASCA (right) 
(caSNP: rs9930307; caPeak: chr16: 9,805,221-9,805,420). (d) The expression of TFs in which motifs are 
disrupted by rs9930307. (e)The motif logo of TP53 and the position disrupted by rs9930307. (f) The box 









Tissue acquisition and cell culture of phNPCs 
Human fetal brain tissue was obtained from the UCLA Gene and Cell Therapy Core 
following IRB regulations. The tissue is often fragmented during acquisition from the surgical 
procedure. In the lab of Daniel Geschwind, flat, thin pieces of tissue that have the morphology of 
developing cortex were selected, and in some cases the tissue was sufficiently intact to be 
certain of cortical identity. Presumed cortical tissue from 14-21 gestation weeks was dissociated 
into a single cell suspension, cultured as neurospheres, plated for a low number of passages 
(2.5 ± 1.8 s.d.) on laminin/fibronectin and polyornithine coated plates, and then cryopreserved 
as human neural progenitors (HNPs) following our previous work (Stein et al., 2014).
 Cryopreserved HNPs were shipped to UNC Chapel Hill after a signed material transfer 
agreement by both institutions. All proliferation, differentiation, sorting, library preparation, and 
analysis were performed at UNC Chapel Hill. In total, HNPs from 92 donors were cultured. 
Donors were thawed in “rounds” of approximately 10 donors, so as to create a manageable 
workload of cell-culture (Supplemental Figure 3.1a).  
Donors were randomly assigned into groups and thawed 3 weeks apart.  We performed 
specific experimental events on the same day of the week and had the same interval of time 
between events for each round. Experimental events included thawing cells, feeding cells, 
splitting cells, counting and plating cells, washing cells prior to differentiation, coating plates with 
attachment factors, adding virus, lifting cells for sorting, sorting, and ATAC-seq library 
preparation. As much as possible, the same researcher performed the same experimental 
events. We documented if a different researcher performed an experimental event in the 
database described below. To determine the impact of different rounds, we cultured cells from 
the same donors in different rounds as technical replicates, for progenitors (N_donor=11, 
N_replicate=13, in round 1-7,12 and 13) and neurons (N_donor=4, N_replicate=4, in round 
2,6,12 and 13).  
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We thawed cells on a Monday (Supplemental Figure 3.1a). HNPs were cultured for 8 
days using full feeds of proliferation media (1x proliferation media; see stock preparation and 
media tables below). On day 9, HNPs were split 1:2 and proliferated with half feeds of 
proliferation media with twice the concentration of growth factors (2x proliferation media) from 
day 10 to day 14. On day 15, HNPs were split 1:3 and proliferated with half feeds of 2x 
proliferation media from day 16 to day 21. On day 22, cells were plated for differentiation onto 8 
x 6-well plate wells per donor at a concentration of 42,000 cells/cm2 (differentiation library 
preparation wells). Two x 6-well plate wells were also plated for ATAC-seq preparation of 
progenitor cells (progenitor library preparation wells) in 1x proliferation media. On day 23, all 
differentiation wells were washed three times with Neurobasal A and then fed with 1x 
differentiation media (see media tables below). On day 24, the progenitor cells in proliferation 
media were lifted with trypsin and ATAC-seq libraries were prepared for progenitors. From day 
24 through day 84 cells were half fed every Monday, Wednesday and Friday with 2x 
differentiation media. Virus for labeling neurons (AAV2-hsyn1-eGFP; 
https://www.addgene.org/50465/; acquired from the UNC Vector Core; (Thiel et al., 1991)) was 
added at 20,000 MOI for library preparation wells on day 64. On day 84, cells were lifted using 
Papain (Worthington) with DNase (Worthington) and sent to cell sorter (BD FACS Aria II or 
Sony SH800S) to sort for live neurons labeled with GFP.  Labeled GFP neurons were collected 
and aliquoted for immediate ATAC-seq library preparation of the neuron cell-type. 
All cultures were visually evaluated and ranked with a subjective measure of cell health 
before ATAC-seq library preparation. Cell health was based on morphology and growth with the 
highest rank of 2 (mostly healthy cells by brightfield microscopy) and the lowest ranking (many 




Proliferation media table 
Proliferation base Proliferation 1x Proliferation 2x 
Item  Volume Item  Volume Item  Volume 


























BIT 9500  (Stemcell 
Technologies; 09500) 
10% LIF (Life 
Technologies; 
PHC9481) 




















1 μg/mL     
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Differentiation media table 
Differentiation base Differentiation 1x Differentiation 2x 
Item  Volume Item  Volume Item  Volume 




















B27 (Life Technologies; 
17504-044) 
2% BDNF (Life 
Technologies; 
PHC7074) 


















Plate coating stock table 
Proliferation 1x Differentiation 1x 
Item  Concentration Item  Concentration 
Fibronectin (Sigma-Aldrich; 
SLBN9832V) 









Library Preparation for human neural progenitors and neurons 
Library preparation was conducted using the published ATAC-seq protocol (Buenrostro 
et al., 2015). ATAC-seq libraries were prepared immediately following cellular dissociation.  
Progenitor nuclei were counted using a hemocytometer while neuron nuclei were counted 
during sorting. 50,000 nuclei were aliquoted into the first step of the ATAC-seq published 
protocol. Libraries were prepared following the published instructions except that the last clean 
up step was modified to use KAPA pure beads (AmpureXP beads at a 1:1 ratio to remove 
dNTPs, salts, primers or primer dimers) instead of Qiagen Minelute clean-up kit. All libraries 
were sequenced to a minimum depth of 13.6M and an average depth of 25.5M using 50 bp PE 
sequencing on an Illumina HiSeq2500 or MiSeq machine (Supplemental Figure 3.1b). In total, 
we acquired 98 ATAC-seq libraries from progenitors (Ndonor=85, Nlibraries replicated=13) and 70 
ATAC-seq libraries from neurons (Ndonor=66, Nlibarary replicated=4). All libraries were sequenced to 
an average depth of 25.5 (± 7.21 s.d.) million read pairs (Supplemental Figure 3.1b), which 
resulted in an average depth of 14 (± 4.8 s.d.) million reads pairs per sample after filtering for 
mitochondrial contamination and duplicates. We performed a sensitivity analysis for read depth 
vs peak calling that showed greater than 15 million filtered read pairs per library led to a fewer 
 62 
number of new peaks called, indicating a reasonable balance between read depth and peaks 
called on the libraries generated here (Supplemental Figure 3.2a). 
Recording technical variables and randomization 
To reduce the impact of batch effects on interpretation of our results, we attempted to 
either have no batches when possible (e.g., perform all experiments using the same lot of a 
reagent) or when this was not possible, randomize technical variables (round a donor was 
thawed in, sequencing pool) such that they had minimal correlation with variables of interest. In 
order to extensively document the impact of technical variables on outcome measures, we 
maintained a relational MySQL database which allowed us to keep track of many technical and 
biological variables throughout each experimental event. Each downstream ATAC-seq library 
preparation therefore is able to be tracked back to all technical and biological variables 
associated with its cell culture. The variables recorded were: 
Media: Basal media lots, growth factor lots, supplement lots, antibiotic lots; Virus: Lot 
number; Donor: sex inferred from genotype; gestation week; Culture: passage, round, thaw 
date, each split date, split ratio, trypsin lot, PBS lot, polyornithine lot, fibronectin lot, plate, and 
well position, cells per well, date of virus addition, differentiation time, date of differentiation 
media addition, person plating for differentiation, virus used, person performing splits, person 
performing virus addition, virus lot, virus multiplicity of infection (MOI), laminin lot, dissociation 
lot, person performing dissociation of neuronal cultures; Cell sorting: Sort date and time, number 
of live cells, number of GFP+ cells, total number of cells, FACS machine; ATAC-seq library 
preparation: number of cells input to the library preparation, person performing the cell lifting, 
lysis date, PBS lot, lysis buffer batch, Illumina Kit lot, PCR master mix lot, PCR clean up kit lot, 
number of time pipetting up and down during lysis, number of times pipetting up and down 
during transposase reaction, transposase reaction volume, barcode indices used for 
multiplexing of each sample, number of PCR cycles added in the ATAC-seq protocol, final DNA 
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concentration after library preparation complete; Sequencing: sequencing date, sequencing 
company, type of sequencer, read length.  
Randomization was performed multiple times. First, randomization was performed to 
assign each donor to a thawing “round”. Randomization was performed at this stage by 
randomly ordering all donors and selecting those to go in each round (generally about 10 
donors per round). After culture and library preparation were complete, randomization was 
performed to assign each library preparation to a pool for sequencing. Randomization was 
performed using custom R code to minimize the correlation of sequencing pool with 
concentration of the library, barcode index (assuring that no barcodes were represented in more 
than one pool), cell type (either neuron or progenitor), round cells were cultured in, and donor. 
ATAC-seq data pre-processing 
Sequencing reads were first quality controlled via fastqc (v0.11.7) to check for sequence 
quality in each library. We observed high quality sequencing for all libraries (PHRED > 20, 
average duplication rate = 43.07% which is almost entirely mtDNA contamination (Supplemental 
Figure 3.1e) which is in agreement with previous studies using the same ATAC-seq method (de 
la Torre-Ubieta et al., 2018), and average GC content = 45%) 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Sequencing adapters were 
removed using BBMAP/BBDUK (https://jgi.doe.gov/data-and-tools/bbtools/bb-tools-user-
guide/bbduk-guide/). We also calculated the number of total reads, the number of unique non-
mitochondrial reads, duplicate rate, mitochondrial duplicate rate, TSS enrichment score, and 
FRiP score (The fraction of reads in called peak regions) for neuron samples and progenitor 
samples to check the library quality using atacqv (Orchard et al., 2020). 
Then, sequencing reads were mapped to the human genome including decoy 
sequences (GRCh38/hg38) using bwa mem (H. Li, 2013) (v0.7.17) and WASP (van de Geijn et 
al., 2015) to remove mapping bias at any bi-allelic SNP using imputed genotype data from each 
sample. Duplicate reads were then removed using WASP. Only uniquely mapped reads 
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mapping to chr 1-22 , X and Y were kept (mitochondrial genome and unmapped contigs were 
removed) using samtools (H. Li et al., 2009) (v1.9). Sequencing reads mapped to ENCODE 
blacklist regions 
(http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeMapability/wgEncode
DacMapabilityConsensusExcludable.bed.gz, converted to hg38 using UCSCtools/liftOver 
(v320)), were then removed by bedtools (Quinlan & Hall, 2010) (v2.26).  
We did a sensitivity analysis for peak calling using pre-processed bam files. It showed 
acquiring 9x higher read depth resulted in only 70,000 additional peaks by MACS2 (J. Feng et 
al., 2011) https://github.com/taoliu/MACS (Supplemental Figure 3.2a). So we reasoned that our 
acquired sequence depth obtained a reasonable balance between additional read depth and 
number of peaks called. We calculated the insert size of pre-processed bam files using Picard 
tools (v2.18.22). The insert size histogram shows clear periodicity representative of preferential 
Tn5 binding around nucleosomes (Supplemental Figure 3.2b). 
To ensure independence, we randomly selected one library from each donor for each 
cell-type (technical replicates where one donor was cultured multiple times for a given cell-type) 
were excluded. Peaks were called for these selected samples (N_Neuron=61, 
N_Progenitor=76) using CSAW (Lun & Smyth, 2016) (v1.16.1), which identifies peaks with 
smaller peak length than previous methods (MACS2 and DiffBind) and showed higher 
enrichment at active regulatory elements such as enhancer and promoters (data not shown). 
For CSAW, peaks were identified in 10 bp bins with average read number greater than 5 across 
all samples (both neurons and progenitors). Bins directly next to each other (100 bp minimum 
distance) were merged to call a peak. In total, CSAW identified 90,227 peaks. 
R v3.4.1 was used for all subsequent analyses. The number of reads within each 
CSAW-called peak were counted and then normalization factors for each peak across samples 
were calculated accounting for GC content, peak width, and total number of unique non-
mitochondrial fragments sequenced using conditional quantile normalization (K. D. Hansen et 
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al., 2012) from the cqn package (v1.28.1). Variance stabilizing transformed (VST) counts were 
calculated using DESeq2 (Love et al., 2014) (v1.22.2) for batch effect correction and differential 
accessibility analysis by limma (Ritchie et al., 2015) (v3.38.3).  
As two different sorters were used to sort GFP+ neurons (63 neuron cell lines (Ndonor=61) 
for one sorter and 7 cell lines (Ndonor=5) for another sorter), and we detected that sort location 
had a strong effect on PCA from neuron samples, sorter locations in neuron VST counts were 
first corrected (limma batcheffectremove()) (Supplemental Figure 3.2c). Corrected neuron VST 
counts and progenitor VST counts were combined so that the potential batch effect from cell 
culture rounds were corrected (limma removeBatchEffect).  
Mycoplasma contamination checks 
To check if there was any contamination from mycoplasma while in culture, we 
downloaded 98 mycoplasma genomes (from NCBI) and then mapped all ATAC-seq data to 
every mycoplasma genome. Less than 0.01% of each ATAC-seq sample mapped to any 
mycoplasma genome, which demonstrated that our cultures were not contaminated with 
mycoplasma. 
Replicate correlations, principal component analysis, and correlation with technical factors 
To determine the reliability of our experiment, we cultured the same donor multiple 
times. We correlated the batch corrected VST counts in CSAW peaks for neuron and progenitor 
replicates either within donors or calculated correlations across donors (Supplemental Figure 
3.2d). The correlations of replicates within donors are higher than that of samples across donors 
in both neuron and progenitor samples.  
The principal component analysis for batch corrected VST counts for all samples was 
done using the prcomp() R function. Then the correlations for the first 10 PCs and technical and 
biological variables that we recorded were calculated using R. The technical variables include 
round of cell culture and sorter locations (only in neurons). Significant correlations with technical 
variables were removed after batch correction (Supplementary Figures 2e-2f).  
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ATAC-seq differential accessibility analysis 
In order to find differentially accessible peaks across cell type controlling for technical 
factors, the dependent variable was the batch corrected number of reads within CSAW peaks 
and the linear regression model independent variables included a regressor for cell type (neuron 
or progenitor) and a factor regressor for donor IDs included in the analysis. 
Enrichment of peaks within annotated regions of the genome 
Enrichment of differentially accessible peaks within annotated genetic regions of the 
genome or epigenetically annotated regions of the genome was calculated using the ratio 
between the (#bases in state AND overlap feature)/(#bases in genome) and the [(#bases 
overlap feature)/(#bases in genome) X (#bases in state)/(#bases in genome)] as described 
previously by the Roadmap Epigenomics Consortium (Roadmap Epigenomics Consortium et 
al., 2015). The significance of this enrichment was calculated using a binomial test as in the 
GREAT algorithm (McLean et al., 2010).  
Chromatin state definitions from an imputed 25-state model were derived from fetal brain 
tissue (E081) and other in vivo tissues/cell types by the Roadmap Epigenomics project (Ernst & 
Kellis, 2015; Roadmap Epigenomics Consortium et al., 2015) and acquired from 
(http://www.broadinstitute.org/~jernst/MODEL_IMPUTED12MARKS/) after liftOver to hg38 
(0.001% of peaks could not be lifted over). We generated the following 
combined states by merging states of similar genomic context:  
Promoter(2_PromU, 3_PromD1, 4_PromD2, 22_PromP, 23_PromBiv), Enhancer (13_EnhA1, 
14_EnhA2, 15_EnhAF, 16_EnhW1, 17_EnhW2, 18_EnhAc), Heterochromatin (21_Het), 
Quiescent (25_Quies), Transcribed (1_TssA, 5_Tx5’, 6_Tx, 7_Tx3', 8_TxWk, 9_TxReg, 
10_TxEnh5', 11_TxEnh3', 12_TxEnhW), Polycomb (24_ReprPC) and ZNF_Rpts 
(20_ZNF/Rpts). 
Locations of ATAC-seq peaks in fetal brain tissue were acquired from previously 
published work (de la Torre-Ubieta et al., 2018). After liftOver to hg38, 0.001% of peaks could 
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not be lifted over.  
Gene ontology analysis at the TSS for differentially accessible peaks (Supplementary 
Figure 3) was completed by first overlapping differentially accessible peaks with a region 2kb 
upstream and 1kb downstream of the TSS of genes defined by Homo sapiens gene ensembl 
version 78 GRCh38.p12. Protein-coding genes with promoter overlapped with selected 
differentially accessible peaks ( |LFC|>0.5 ) were input into the TopGO (Alexa & Rahnenfuhrer, 
2010) package (v2.34.0), with all protein-coding genes as background.  
Gene based annotations of the genome were derived from Homo sapiens gene ensembl 
version 78 (GRCh38.p12) for plotting loci.  
Differential transcription factor binding analysis 
We performed an analysis to identify motifs with differential prevalence in differentially 
accessible peaks (Supplemental Table 3.2, Figure 3.3b). To avoid the bias caused by different 
numbers of progenitor peaks and neuron peaks, here we only used top 2000 progenitor peaks 
with highest LFC, and  top 2000 neuron peaks with lowest  LFC. 
Potential transcription factor binding sites were called in the human genome using 
TFBSTools (v1.4.0) with a minimum score threshold of 80% based on position weight matrices 
from the JASPAR2016 (Mathelier et al., 2016) core database, selecting vertebrates as the 
taxonomic group. Only the most recent version of the PWM for a given TF was used. To select 
regions of the genome that are highly conserved among vertebrates, and likely functional, 100-
way phastCons (Pollard et al., 2010) scores > 0.4 in regions ≥ 20 bp were saved (downloaded 
from UCSC genome browser). Only TFBS sites within conserved regions were retained for 
further analyses. Differential motif enrichment analysis was performed using a logistic 
regression model to identify motifs present more often in progenitor peaks as compared to 
neuron peaks, or vice versa. Logistic regression explicitly controlled for differences in peak 
width and peak conservation between progenitor and neuron differentially accessible peaks. 
The analysis was implemented in R as: glm(TFBS ~ ProgenitorNeuron + peakwidth + 
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conservedbppercent, family = "binomial"). The dependent variable (TFBS) was a binary 
representation of whether each differentially accessible peak contained a motif of a TF or not. 
The independent variable of interest marked whether a peak was progenitor 
(ProgenitorNeuron=1) or neuron (ProgenitorNeuron=0). Other covariates included peak width 
(peakwidth) and the percentage of the peak with conservation (conservedbppercent) as defined 
above. Significant differential motif enrichment was determined by FDR adjusted P-value < 0.05 
threshold of the ProgenitorNeuron covariate. progenitorTFs were defined as significantly 
differentially enriched motifs present more often in progenitor peaks as compared to neuron 
peaks, whereas neuronTFs were defined as significantly differentially enriched motifs present 
more often in neuron peaks as compared to progenitor peaks. 
Genotype pre-processing 
Genotyping was performed using Illumina HumanOmni2.5 or HumanOmni2.5Exome 
platform. SNP genotypes were exported into PLINK format. SNP marker names were converted 
from Illumina KGP IDs to rsIDs using the conversion file provided by Illumina. Quality control 
was performed in PLINK v1.90b3 (Chang et al., 2015) (Supplemental Figure 3.4a). SNPs were 
filtered based on Hardy-Weinberg equilibrium (--hwe 1e-6), minor allele frequency (--maf 0.01), 
individual missing genotype rate (--mind 0.10), variant missing genotype rate (--geno 0.05) 
resulting in 1,760,704 directly genotyped variants. Multidimensional scaling (MDS) analysis of 
genotypes from all individuals used in the study was completed in PLINK v1.90b3. We did not 
see a strong effect of genotyping batch on genotype data based on MDS1 and MDS2 from 
different genotyping batches. We used PLINK v1.90b3 to call sex from genotype data. For the 
samples with unkown sex from genotype data, we ploted PCA (PC1 vs PC2) of ATAC-seq 
reads on sex chromosomes (chromsome X and Y) to identify sex (Supplemental Figure 3.4b). 
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Sample Swap and contamination Identification 
Quality controlled genotype data and BAM files were used to identify any sample swaps 
between the ATAC-seq and genotyping data using VerifyBamID v1.1.3 (Jun et al., 2012). We 
removed any BAM file with [FREEMIX] > 0.02 or [CHIPMIX] > 0.02 (N_donor=5), and corrected 
sample swaps (N_donor=7). After this filtering step, our sample size was 76 unique donors for 
progenitor samples and 61 unique donors for neuron samples for the caQTL studies.  
Imputation 
Filtered genotype data were pre-phased by SHAPEIT (Delaneau et al., 2011) v2.837. 
Minimac4 (Das et al., 2016) (v1.0.0) was used to impute the filtered genotyped markers using 
reference haplotype panels from the 1000 Genomes Project (The 1000 Genomes Project 
Consortium Phase 3) that contain a total of 37.9 million SNPs in 2,504 individuals from any 
ancestry, including those from West Africa, East Asia and Europe. We separated chrX into 
pseudoautosomal regions and non-pseudoautosomal regions, then pre-phased and imputed 
them separately. 
After genotype imputation, we extracted the genotypes for all individuals assayed for 
chromatin accessibility. Imputed genotype data were filtered for variant missing genotype rate < 
0.05, Hardy-Weinberg equilibrium p-value < 1 x 10-6 and minor allele frequency (MAF) 1%. We 
retained variants with imputation quality Rsquared > 0.3 by Minimac4, resulting in ~13.6 million 
SNPs.  
caQTL mapping  
We calculated multidimensional scaling (MDS) for genotype data of our samples and 
genotype data from HapMap3 
(https://www.sanger.ac.uk/resources/downloads/human/hapmap3.html) following the protocol 
from ENIGMA consortium (http://enigma.ini.usc.edu/wp-
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content/uploads/2012/07/ENIGMA2_1KGP_cookbook_v3.pdf). We identified multiple ancestries 
of donors of our samples in the MDS plot (MDS1 vs. MDS2) (Supplemental Figure 3.4c). 
To control for population stratification and cryptic relatedness of our samples when 
mapping caQTLs, we ran caQTL analysis with EMMAX (H. M. Kang et al., 2010), which 
accounts for population structure using a genetic relatedness or kinship matrix. We used the 
emmax-kin function (-v -h -s -d 10) to create the IBS kinship matrix for each tested genetic 
variant from non-imputed genotype data excluding all genetic variants on the same 
chromosome with the tested genetic variant (Price et al., 2010).  
We performed proximal caQTL mapping using a window of 100 kb up- and down-stream 
of the center of 90,227 csaw peaks using VST normalized read counts of each peak for each 
donor (Supplemental Figure 3.4a). We performed caQTL analysis separately in neurons and 
progenitors using imputed genotype data. To prevent results driven by only one minor allele 
homozygous donor, we retained the variants where the number of minor allele homozygous 
donors is not 1 and at least 2 heterozygous donors. In addition to the kinship matrix (Price et al., 
2010), for the progenitor caQTLs, we include sorter locations, the first 10 genotype MDSs and 8 
PCs across VST counts of the chromatin accessibility data. For neurons, we include the first 10 
genotype MDSs and 7 PCs of VST counts of the chromatin accessibility data. These PC 
numbers were chosen to maximize the number of caQTLs for each cell-type. Nominal EMMAX 
p-values were corrected for multiple testing using the software eigenMT (J. R. Davis et al., 
2016) and Benjamini–Hochberg FDR correction (Benjamini & Hochberg, 1995) within neuron 
caQTLs and within progenitor caQTLs separately (eigenMT-FDR < 0.05).  We retained the most 
significant caSNP for each significant caPeak that survives the eigenMT-FDR threshold, and 
defined the caSNP-caPeak pair as the most significant caQTL for a given caPeak. The percent 
variance explained was calculated using the method from a previous study (Shim et al., 2015).  
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Identify correlated caPeaks 
To identify correlated caPeaks, we defined primary caPeaks as the caPeaks harboring 
caSNP(s). We then defined secondary caPeaks as peaks which are associated with the caSNP 
of a primary peak. We calculated Perason’s correlation between the primary caPeak and all 
caPeaks within +/- 2Mbp from the center of its secondary caPeak (including the secondary 
caPeak), then corrected the Pearson’s correlation p-value using the Benjamini–Hochberg FDR 
correction (Benjamini & Hochberg, 1995). If the secondary caPeak was significantly (FDR < 
0.05) correlated with the primary caPeak, this caSNP-caPeak pair was classified as “caSNP in 
correlated caPeak”. 
Allele specific chromatin accessibility  
We used GATK tools to extract allele specific read counts for every SNP. We first filtered 
for SNPs within each donor that had sufficient read depth by retaining SNPs with total counts 
greater than or equal to 10 for neuron and progenitor samples, separately. Then to calculate 
allele specific chromatin accessibility, we retained those SNPs with average read counts for all 
heterozygous donors greater than or equal to 15. Finally, we retained only those SNPs that 
meet these previous thresholds for at least 5 heterozygous donors. DESeq2 was used to 
calculate the LFC (Alternative read counts/Reference read counts) for filtered SNPs across all 
heterozygous donors. The non-heterozygous donors were excluded from the differential 
analysis for each SNP using sample-specific weights, and maximum likelihood estimation was 
used for dispersion estimation followed by Wald tests of the estimated LFC. FDR < 0.05 was 
used as the threshold for significance. 
Bulk fetal brain eQTL mapping 
Bulk fetal cortical wall eQTL data described in a previous publication (Walker et al., 
2019), was re-analyzed in this study with the following modifications: (1) we used a linear mixed 
model implemented in EMMAX to more stringently control for population stratification, and (2) 
we add 23 more donors to the analysis because these donors were genotyped after the 
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publication of the previous manuscript. rRNA-depleted RNA-seq data from flash frozen human 
fetal brain cortical wall tissues derived from 235 donors at 14-21 gestation weeks were used for 
eQTL analysis. 41% samples in the progenitor eQTL analysis were overlapped with the samples 
in fetal brain eQTL analysis, and 36% samples in the neuron eQTL analysis were overlapped 
with the samples in fetal brain eQTL analysis. Gene based annotations of the genome were 
derived from Homo sapiens gene ensembl version 92 (GRCh38) for eQTLs. Only genes which 
are expressed in more than 5% of donors with at least 10 counts were included in the analysis. 
VST normalized expression values were used as phenotypes for eQTL analysis. Genomic DNA 
from human fetal brain cortical wall tissues derived from 235 donors at 14-21 PCW was 
extracted. Each donor tissue was genotyped on a dense array (Illumina Omni 2.5+Exome) and 
imputed to a common reference panel (1000 Genomes; described above). Variants were 
retained in the analysis if there were at least 2 heterozygous donors and no homozygous minor 
allele donors, or if there were at least 2 minor allele homozygous donors. For the effect size 
comparison analysis fetal brain eQTL vs caQTLs (Figure 3.2e-3.2f), we subsampled fetal brain 
eQTL donors to the same sample size as the caQTL while maintaining the population 
composition similar to the larger donor list.  
Cis-eQTL analysis was performed by evaluating association between each gene’s 
expression and variants within ±1 Mb window of transcription start site of each gene by 
implementing linear mixed model association software, EMMAX (H. M. Kang et al., 2008). All 
markers on the chromosome of this candidate marker were excluded from the IBS kinship 
matrix generated with emmax-kin function (-v -h -s -d 10), and added as a random variable into 
linear mixed model for association test. In addition to kinship matrix, 10 MDS components of 
genotype  and first 10 PCs of gene expression were included into the covariate matrix. After 
association, nominal p-values were corrected for multiple testing using the eigenMT and 
Benjamini Hochberg FDR correction, and associations with lower than 5% eigenMT-FDR 
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threshold value were accepted as significant. We retained only the most significant eSNP for 
each significant eGene in this study. 
M-value calculation  
Using Metasoft (v2.0.1) (B. Han & Eskin, 2012), we calculated m-values between 
caQTLs and eQTLs. First, we selected the most significant caSNP for a given caPeak in either 
neurons or progenitors. Then, we found the SNP-Gene pair corresponding to that caSNP in bulk 
fetal brain or in the cell type specific eQTL (for sharing in Figure 3.2d). The caSNP may or may 
not be an eSNP and the eSNP may be associated with multiple genes. Then, we selected the 
most significant eSNP for an eGene and found the corresponding SNP-Peak pairs in 
neuron/progenitor caQTL analysis (for sharing in Figure 3.2f, Supplementary Figure 3.4e).The 
eSNP may not be a caSNP and the eSNP may be associated with multiple peaks. We 
calculated the m-values for SNPs in all the SNP-Peak-Gene combinations we found above. The 
SNP-Peak-Gene combinations with m-value greater than 0.9 in both caQTL and eQTL analysis 
are identified as shared SNP-Peak-Gene combinations. 
Using the same approach, we identified shared neuron/progenitor SNP-Peak-Gene 
combinations using the most significant  neuron/progenitor caSNPs and the most significant 
neuron/progenitor eSNPs.  
Integration of caQTLs with eQTLs 
To identify RE-gene pairs neurons/progenitors, we listed SNPs with pairwise LD r2 > 0.8 
with the caSNPs in the caPeak using genotype data from neuron samples/progenitor samples, 
separately, then we listed SNPs with pairwise LD r2 > 0.8 with index eSNP using the LD matrix 
from neuron samples/progenitor samples for cell type specific eQTL analysis. We labelled the 
caPeak and the eGene as an RE-Gene pair if any SNP from the above two categories is 
overlapped in neurons/progenitors (Supplemental Table 3.5).  
To identify RE-gene pairs in fetal bulk cortical tissue eQTLs we listed SNPs with pairwise 
LD r2 > 0.8 with the caSNPs in the caPeak using genotype data from neuron samples/progenitor 
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samples, separately, then we listed SNPs with pairwise LD r2 > 0.8 with index eSNP using the 
LD matrix from fetal brain samples for fetal bulk cortical eQTLs. We labelled the caPeak and the 
eGene as a RE-Gene pair if any SNP from the above two categories is overlapped in fetal brain 
tissues (Supplemental Table 3.5). 
Estimation of sharing via π1 
The R package ‘qvalue’ (v2.20.0) (Dabney et al., 2010) was used to estimate the π0 of 
the input nominal p values of the cell type specific eQTL and caQTL data, then we used 1 minus 
the estimated π0 to get π1. We found all the neuron SNP-Peak pairs using the most significant 
progenitor caSNP-caPeak pairs, then used the nominal p values of the neuron SNP-Peak pairs 
to estimate the proportion of true neuron caQTLs in the SNP-Peak pairs (π1). In the same way, 
we estimated the proportion of true progenitor caQTLs using the most significant neuron 
caSNP-caPeak pairs. For neuron eQTLs, we listed all the neuron SNP-Gene pairs using the 
most significant progenitor eSNP-eGene pairs, then used the nominal p values of the neuron 
SNP-Gene pairs to estimate the proportion of true neuron eQTLs in the SNP-Gene pairs (π1). 
Similarly, we estimated the proportion of true progenitor eQTLs using the most significant 
neuron eSNP-eGene pairs. 
Comparison to adult dorsolateral prefrontal cortex caQTLs  
We acquired adult DLPFC ATAC-seq data from Sage Bionetworks-Synapse website via 
the psychENCODE Knowledge Portal under the accession number [syn5321694] 
https://www.synapse.org/#!Synapse:syn5321694 (Bryois et al., 2018). To calculate the overlap 
of caQTLs between cultured neural cells and adult DLPFC, we first extracted read counts within 
adult DLPFC peaks in ATAC-seq data from neurons and progenitors. We found 65,573 DLPFC 
peaks have an average read counts greater than 5 across all neuron and progenitor samples, 
and these peaks demonstrate cell-type/tissue type specificity in chromatin accessibility as 
visualized in a PCA plot (Supplemental Figure 3.7a-3.7b). Then using the shared peaks and the 
same SNPs with DLPFC caQTL, we re-mapped caQTLs in neurons and progenitors using the 
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same models as previously described. We found 27 significant neuron caQTLs and 35 
significant progenitor caQTLs using the same eigenMT-FDR threshold as previously used in 
caQTL mapping in neurons and progenitors. Using the same SNP-Peak pairs from DLPFC 
caQTLs, we found the π1 is 0.001 in neuron caQTLs and 0.04 in progenitor caQTLs, which 
indicates a highly temporal specificity in caQTLs. We also found low correlations of effect sizes 
in significant neuron/progenitor caQTLs and DLPFC caQTLs (Supplemental Figure 3.7c).  
Determining the impact of caSNPs on motifs 
In order to determine if genetic variation within peaks impacts transcription factor (TF) 
binding motifs, we used motifBreakR (v1.14.0) (Coetzee et al., 2015) to map known TF motifs to 
the sequence surrounding the neuron-specific/progenitor-specific significant caSNPs located in 
an ATAC-peak have significant association with the caPeak (parameter setting: threshold = 1e-
4). All annotated motifs (in total 630 TF motifs) are from JASPAR2016 vertebrate in MotifDb 
(1.26.0) (Shannon & Richards, 2014). We calculated the relative entropy (parameter setting: 
method=”ic”) for reference allele and alternative allele, then only kept the TFBSs which are 
strongly affected by the SNPs (motifbreakR parameter setting: effect=”strong”). We calculated 
the enrichment of neuron and progenitor caSNP-disrupted motifs in accessible peaks using the 
binomial test (McLean et al., 2010). First, we found all TFBSs for a given TF in accessible 
regions (n) and calculated the fraction of base pairs of the motif compared to the overall base 
pairs of accessible peaks. Then, we counted the number of SNP-disrupted motifs for this TF (k). 
The final step was to calculate P=Prbinom(x>=k|n,p) using the binomial test to get the significance 
of the enrichment. We further filtered the enrichment results by differential expression from the 
same set of cells, and only kept the TFs with cell-type specific caSNP-disrupted motifs 
significantly enriched in accessible regions and significantly differentially expressed in the cell 
type (Aygün et al., 2020). 
 76 
To determine if the motif disrupting allele is associated with increased/decreased 
chromatin accessibility, we first identified the motif-disrupting allele. The motif-disrupting allele 
decreases the relative entropy of the position possibility matrix of a TFBS. Then, we aligned the 
motif-disrupting allele with the effect allele for caQTLs. Finally, we used linear regression to 
determine the relationship between decreased relative entropy and effect size for all motif-
disrupting alleles for this TFBS (lm(effect size ~ decreased relative entropy+0). We fit the line 
through zero because we assume that if a motif is not disrupted by an allele, it will also have no 
effect on chromatin accessibility. The significance of the coefficient for effect size on decreased 
relative entropy was tested and the p-values adjusted to control FDR (Benjamini & Hochberg, 
1995) (Figures 6c-6f).  
Partitioned Heritability  
Partitioned heritability was measured using LD Score Regression v1.0.0 (Finucane, 
Bulik-Sullivan, Gusev, Trynka, Reshef, Loh, Anttilla, Xu, Zang, Farh, Ripke, Day, ReproGen 
Consortium, et al., 2015) to identify enrichment of GWAS summary statistics among 
differentially accessible peaks.  First, an annotation file was created which marked all HapMap3 
SNPs that fell within neuron peaks or progenitor peaks. To avoid bias caused by different 
numbers of progenitor peaks and neuron peaks, we randomly selected the same number of 
neuron peaks as progenitor peaks. LD-scores were calculated for these SNPs within 1 cM 
windows using the 1000 Genomes European data. These LD-scores were included 
simultaneously with the baseline distributed annotation file from (Finucane, Bulik-Sullivan, 
Gusev, Trynka, Reshef, Loh, Anttilla, Xu, Zang, Farh, Ripke, Day, ReproGen Consortium, et al., 
2015). Subsequently, the heritability explained by these annotated regions of the genome was 
assessed from these genome-wide association studies: Attention-Deficit/hyperactivity disorder 
(Demontis et al., 2019), autism spectrum disorder (Grove et al., 2019), IQ (Savage et al., 2018), 
major depressive disorder (Wray et al., 2018), Bipolar disorder (E. A. Stahl et al., 2019), 
schizophrenia (Pardiñas et al., 2018), insomnia (P. R. Jansen et al., 2019), educational 
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attainment (J. J. Lee et al., 2018), subjective well-being (Okbay et al., 2016), depressive 
symptoms (Okbay et al., 2016), neuroticism (Nagel et al., 2018), anorexia nervosa (Duncan et 
al., 2017), anxiety (Otowa et al., 2016), Alzheimer's disease (I. E. Jansen et al., 2019), epilepsy 
(International League Against Epilepsy Consortium on Complex Epilepsies, 2018), Parkinson's 
disease (Nalls et al., 2018), brain structures (Grasby et al., 2018). 
The enrichment was calculated as the heritability explained for each phenotype within a 
given annotation divided by the proportion of SNPs in the genome corresponding to the 
annotation and Benjamini–Hochberg FDR correction  (Benjamini & Hochberg, 1995) was used 
to correct for multiple comparisons. 
Co-localization with GWAS data 
We used conditional caQTLs to detect the co-localization of caQTLs with multiple GWAS 
datasets, which are previously listed above in the “Partitioned Heritability” section. First, to 
identify co-localized loci: 1) we listed SNPs with pairwise LD r2 > 0.8 with the caSNPs in the 
caPeak using genotype data from neuron samples and progenitor samples, separately; 2) we 
listed SNPs with pairwise LD r2 > 0.8 with index GWAS SNP (p<5e-8 and exhibited the 
strongest association in upstream/downstream 100kb from the center of this caPeak) using the 
LD matrix from European genotype data from 1000 Genome project phase 3 with population 
code EUR. Second, we labelled the caPeak as a potentially co-localized locus if any SNP was 
shared between the above two categories. Third, we performed a conditional caQTL analysis for 
significant (eigenMT-BH FDR < 0.05) caSNPs conditioning on the index GWAS SNP (Civelek et 
al., 2017). If the caQTL is no longer significant (eigenMT-BH FDR > 0.05), then we called the 
caQTL as a co-localized locus with this GWAS trait.  
Luciferase reporter assay 
DNA fragments of differentially accessible chromatin peaks containing SNPs for 
functional validation were synthesized using Thermo Fisher Scientific’s Gene String service. 
Fragments were amplified by PCR with primers containing KpnI and HindIII restriction sites. 
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Digested fragments were then cloned into the multiple cloning region of the pGL4.23 vector 
(Promega), containing a minimal promoter upstream of the luc2 luciferase reporter gene. To 
generate corresponding alternate alleles, we performed site-directed mutagenesis on the 
cloned, insert-containing luciferase plasmids using the Q5 Site-directed mutagenesis kit (NEB). 
All cloned sequences were verified by Sanger sequencing for the correct mutations and 
analyzed by NanoDrop to ensure high concentration and transfection-grade quality. 
Oligonucleotide sequences used for cloning are listed in Supplemental Table 3.9.  
Human NPCs grown in 96 well plates were co-transfected with 120 ng/well luciferase 
reporter plasmid and 30 ng/well renilla control plasmid (pRL-SV40; Promega) using 
Lipofectamine STEM Transfection Reagent (Thermo Fisher). NPCs were then cultured for 72 
hours prior to processing with the Dual-Glo Luciferase Assay System (Promega). Luciferase 
and renilla expression was measured using a CLAIROStar Plus Plate Reader (BMG Labtech). 
Each luciferase reading was then normalized by its corresponding renilla reading to control for 
transfection efficiency and to calculate RLU. A total of 8 unique donors with at least 3 well 
replicates per plasmid per donor were used for analysis. 
REST ChIP-seq data in H1 cells and neurons differentiated from H1 cells 
We acquired the alignments of REST ChIP-seq data in H1 embryonic stem cells and 
neurons differentiated from H1 cells from the ENCODE portal (C. A. Davis et al., 2018; 
ENCODE Project Consortium, 2012) (https://www.encodeproject.org/) with the following 
identifiers: ENCSR000BTV and ENCSR000BHM. We normalized the read counts by library 






CHAPTER 4 DETECTION OF CELL-TYPE SPECIFIC IMPRINTED REGULATORY 
ELEMENTS DURING HUMAN NEURONAL DIFFERENTIATION 
 
4.1 Introduction 
Genomic imprinting leads to monoallelic gene expression or chromatin accessibility in a 
parent-of-origin specific manner. Loss of function mutations in the non-imprinted allele lead to a 
variety of brain and non-brain disorders discovered through parent of origin association studies 
(Ishida & Moore, 2013; Mozaffari et al., 2019; Nicholls, 2000; Perez et al., 2016). Identification 
of imprinting within specific cell types is critical for interpreting results of parent of origin 
association studies and may be useful for developing therapeutics for these disorders (Wolter et 
al., 2020).  
Genomic imprinting is most often studied in mice where breeding is designed and high-
throughput sequencing data (RNA-seq data and genotype data) is acquired from parents and 
their offspring. Heterozygous genetic markers then allow the separation of maternal vs paternal 
expression (Babak et al., 2008; Gregg et al., 2010; Laukoter et al., 2020; X. Wang et al., 2008). 
Imprinted genes are expressed more often in brain compared to non-brain tissues (Perez et al., 
2015). Genomic imprinting shows key functions in neurodevelopmental processes including 
neural progenitor expansion, migration and differentiation, and cell polarization in mouse brains 
(Perez et al., 2016).  
Even though many genes show conserved imprinting status between mouse and 
humans, some showed imprinting restricted to humans (Nakabayashi et al., 2011). In humans, 
many imprinted genes are also expressed during neural development or in the adult brain 
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(Babak et al., 2015). Previous studies identified imprinted genes in different human 
tissues or cells (Babak et al., 2015; Baran et al., 2015; Santoni et al., 2017), yet there is still a 
lack of understanding on the regulation of genomic imprinting at cell-type level during 
neurogenesis, which is important because imprinting processes are known to affect 
development and imprinting is often found in the brain (Barlow & Bartolomei, 2014).  
The regulatory elements (REs) controlling genomic imprinting, called imprinting control 
elements (ICEs), are marked by parental-specific DNA methylation inherited from the sperm or 
egg  (Ferguson-Smith, 2011; Hanna & Kelsey, 2014). These ICEs regulate imprinted gene 
expression in time and space. For example, in non-neural tissues, Grb10 is expressed 
maternally when the promoter is active only on the maternal chromosome. By contrast, in neural 
tissues, Grb10 is paternally transcribed from the promoters that are only active on the paternal 
chromosome (Arnaud et al., 2003; Garfield et al., 2011; Hikichi et al., 2003; Plasschaert & 
Bartolomei, 2015). Identifying ICEs allows a better understanding of mechanisms controlling 
imprinting. 
In humans, it is difficult to obtain both RNA-seq data from child and genotype data from 
both parents on a large scale in order to demonstrate imprinting. Random monoallelic 
expression has been previously used to infer imprinting  in humans in large datasets (Chess, 
2012; Reinius & Sandberg, 2015), but it is still difficult to separate allelically driven from  parent-
of-origin driven expression differences. To remove the allele-specific bias, a more accurate way 
to estimate genomic imprinting is to identify the distribution of allelic ratio (reference/alternative 
allele to total allele counts) across different individuals (Babak et al., 2015; Baran et al., 2015). 
Here, we used the beta-binomial distribution to model the allelic ratio (reference allele to total 
allele counts) distribution across different individuals in order to estimate the dispersion of allelic 
ratio in population, for gene expression (RNA-seq) and chromatin accessibility (ATAC-seq). 
Higher dispersion of allelic ratio indicates a higher likelihood of imprinting expression. Using this 
method, we identify putatively imprinted regulatory elements and genes in neuronal progenitors 
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and neurons without measuring genotypes in parents. By combining the cell-type specific 
genomic imprinting with parent-of-origin genetic association studies, we confirm previously 
identified imprinted genes and REs, note their cell type specificity, and use novel discovered 
REs to explain parent of origin association studies for neurodevelopmental disorders. 
4.2 Results 
Detection of imprinted regulatory elements (REs) and genes in neuronal progenitors and 
neurons 
 
We acquired and genotyped primary human neural progenitor cell (phNPC) lines from 
14-21 gestation week genotyped human fetal brain tissue using a neurosphere isolation 
method, as described previously (D. Liang et al., 2020; Stein et al., 2014). phNPCs were 
cultured in vitro to as progenitor cells and also differentiated into neurons. We FACS sorted the 
virally labeled differentiated neurons after 8 weeks of differentiation (D. Liang et al., 2020). We 
then performed ATAC-seq and RNA-seq to obtain the chromatin accessibility profiles 
(N_Progenitor=76 and N_Neuron=61) and gene expression profiles (N_Progenitor=85 and 
N_Neuron=74) in progenitors and neurons (Figure 3.1A). We identified heterozygous genetic 
variants using imputed genotype data for all donors in progenitors and neurons in order to 
distinguish the two chromosomes, without being able to identify maternal or paternal origin. 
Allele-specific chromatin accessibility and gene expression were then calculated using read 
counts (for the reference allele and the alternative allele) at each accessible/expressed 
heterozygous single nucleotide polymorphisms (SNP) sites (D. Liang et al., 2020). We identified 
19,960 heterozygous SNPs in 12,233 accessible regions and 93,282 expressed heterozygous 
SNPs in 8,875 genes in neurons; and 10,208 heterozygous SNPs in 6,561 accessible regions 
and 63,760 expressed heterozygous SNPs in 8,968 in progenitors.  
To identify SNPs putatively in the imprinted accessible regions or genes, we first 
estimated the dispersion of monoallelic chromatin accessibility or expression. We modeled 
monoallelic chromatin accessibility or gene expression using a beta-binomial distribution at 
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heterozygous SNPs and evaluated the significance of over-dispersion of the allelic ratio (AR = 
reads of reference allele/total reads) using the likelihood ratio test. SNPs with a significant AR 
over-dispersion (FDR < 0.05 across all heterozygous SNPs tested within a given cell type) and 
at least two donors have AR >= 0.8 and at least two donors have AR <= 0.2 were classified as 
putatively imprinted (Figure 4.1A).  
After this analysis and filters, we identified 44 imprinted REs containing 87 SNPs with 
significant allelic bias in neurons (Neuron imprinted REs) and 20 imprinted REs containing 37 
SNPs with significant allelic bias in progenitors (Progenitor imprinted REs) (Figure 4.1B; 
Supplemental Table 4.1). We found many neuron imprinted REs overlapped with the promoters 
of well-known imprinted genes (Figure 4.1B; red points labeled) that are involved in neuronal 
development and differentiation. For example, the imprinted gene MAGEL2 has the highest 
expression in the brain compared with other human adult tissues (S. Lee et al., 2000). Another 
promoter imprinted in neurons is NDN. Both MAGEL2 and NDN are involved in axonal and 
dendritic outgrowth (Syann Lee et al., 2005). Surprisingly, we did not find any progenitor 
imprinted REs overlapped with the promoters of well-known imprinted genes. Human imprinting 
has not been studied before in this cell type, to our knowledge, so these progenitor imprinted 
REs may represent a novel set of imprinted elements. Similarly, multiple novel REs were 
identified in both cell types, which we now nominate as candidate, cell-type specific imprinted 
REs involved in neuronal development.  
We identified 33 neuron imprinted genes containing 116 SNPs and 20 progenitor 
imprinted genes containing 60 SNPs (Figure 4.1C; Supplemental Table 4.2), of which many 
genes have been previously reported as imprinted, such as UBE3A, MEST, GRB10, and MEG3 
(Blagitko et al., 2000; Dindot et al., 2008; Huntriss et al., 2013; X. Zhang et al., 2003), of which 
we found genes like SGCE has important function in cortical neuron differentiation (Grütz et al., 
2017) and ZDBF2 is involved in corticogenesis (Bouschet et al., 2017; Duffié et al., 2014). We 
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also found some new candidates of imprinted genes in progenitors and neurons, such as 
COPG2, DOC2B and ZNF627 (Supplemental Table 4.2). 
In these imprinted genes, we found 9 of them are shared between progenitors and 
neurons. And most of the shared genes are known imprinted genes, like ZDBF2, GRB10, 
PEG10, MEST, MEG3, NDN and SNHG14 (Blagitko et al., 2000; Buccarelli et al., 2020; Ho-
Shing & Dulac, 2019; Kobayashi et al., 2013; Stanurova et al., 2016; Wilkinson et al., 2007; Xie 
et al., 2018). We also found a couple of new imprinted candidate genes in progenitors and 
neurons, such as HM13 and ZNF331. For the imprinted REs, we identified 10 REs showing 
imprinting in progenitors and neurons. Many of these REs overlapped with promoters of genes 
that are not previously known as imprinted genes, such as CRELD1 and EIF2D, which could be 
new candidates for imprinted regulation. We identified many known imprinted genes and REs at 
known imprinted loci, giving us confidence in our statistical approach, and also identified some 
novel ones which can be targets for future study. 
Neuron/Progenitor imprinting at known loci  
A well-known example of an imprinted genomic cluster is the Prader–Willi/Angelman 
Syndrome (PWS/AS) region on human chromosome 15q11–q13 (Nicholls et al., 1998), 
including a group of imprinted genes: NDN, MAGEL2, SNRPN, SNHG14, UBE3A and ATP10A. 
Genetic alterations in the PWS/AS region result in serious neurodevelopmental disorders in a 
parent of origin dependent manner, PWS and AS (Perk et al., 2002), demonstrating important 
function of these imprinted genes during neuronal development. We identified neuron-specific 
imprinted REs that are overlapped with the promoters of MAGEL2, NDN and SNRPN (Figure 
4.2A and 4.2B). Using gene expression in neurons and progenitors, we found neuron-specific 
imprinting of the gene UBE3A (Figure 4.2A and 4.2C), which also in agreement with previous 
studies showing that UBE3A is expressed exclusively from the maternally inherited allele in 
neurons (Hsiao et al., 2019; Martins-Taylor et al., 2014). We identified previously known 
imprinted genes such as NDN (Jay et al., 1997) and SNHG14 (Stanurova et al., 2016) display 
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imprinted expression patterns in both progenitors and neurons (Figure 4.2C), suggesting the 
function of them in neural development and differentiation at the fetal development stage. In the 
PWS/AS region, we found more imprinted REs and genes in neurons than in progenitors, which 
is consistent with a previous study in iPSC-derived neurons (Pólvora-Brandão et al., 2018). We 
also found a progenitor-specific imprinted gene MEG8 (Maternally Expressed 8; Figure 4.2D). 
The aberrant expression of this lncRNA may trophoblast dysfunction and abortion in humans 
(Sheng et al., 2019), indicating the function of MEG8 in early development stage. 
Characterizations of Neuron/Progenitor imprinted REs 
The methylation of CpGs is an important epigenetic modification involved in imprinting in 
mammals (Paulsen & Ferguson-Smith, 2001). To explore the relationship between CpG island 
and imprinted REs in neurons and progenitors, we first calculated the GC content of the 
imprinted REs. We found the GC content is significantly higher in the imprinted REs as 
compared to non-imprinted REs (Figure 4.3A). Then, we found the imprinted REs showed 
significantly higher overlap with human CpG islands than the non-imprinted REs in both neurons 
and progenitors (Figure 4.3B). These results suggest that the methylation of CpGs is involved in 
the genomic imprinting during neuronal development and differentiation. 
To explore the transcription factors (TFs) that bind to imprinted REs in neurons and 
progenitors, we performed an enrichment analysis of motifs in the imprinted REs using binomial 
test (McLean et al., 2010). We retained TFs with  significantly higher expression in the cell type 
where they showed imprinting enrichment (Figure 4.3C). Among TF motifs enriched in neuron 
imprinted REs, we found TFs like ELK4 which is involved in upstream regulation of parent-of-
origin-regulated genes in mice with sleep loss (Tinarelli et al., 2014). These enrichments show 
that within a cell type, the same TFs likely bind to and regulate multiple different imprinted REs. 
Imprinted REs and genes indicating isoform-specific imprinting in neurons 
In neurons, we found the promoter region (chr21:39,385,651-39,386,540) of one isoform 
(ENST00000380713) of the gene GET1 (also known as WRB) showed neuron-specific 
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imprinting (Figure 4.4A and 4.4B). This region in WRB was previously reported as new 
candidate imprinted regions according to DNA methylation analysis using peripheral blood 
samples (Alves da Silva et al., 2016; Docherty et al., 2014), to our knowledge, this is the first 
time this region was suggested as imprinted REs in neurons. Even though little is known about 
the function of GET1, our result suggests the isoform is involved in neuronal differentiation.  
We also found the gene ZNF331 had cell-type and isoform-specific imprinted expression 
patterns (Figure 4.4C and 4.4D). We first found the neuron-specific imprinted RE 
(chr19:53,537,591-53,538,420) overlapped with the isoforms of ZNF331 (ENST00000449416, 
ENST00000504033, ENST00000514374, ENST00000411977, ENST00000511154, 
ENST00000509069, ENST00000509047, ENST00000509585 and ENST00000504940), and 
some of these isoforms (ENST00000449416, ENST00000411977, ENST00000511154, 
ENST00000504033, ENST00000514374, ENST00000509069, ENST00000509047, 
ENST00000509585) showed neuron-specific imprinting expression (Figure 4.4D). However, in 
progenitors, we found other isoforms of ZNF331 (ENST00000513929, ENST00000253144, 
ENST00000502248, ENST00000511593) showed an imprinted expression patterns (Figure 
4.4C). Isoform-specific imprinting of ZNF331 has been previously reported in human LCLs, 
placenta and hydatidiform mole (Court et al., 2014; Daelemans et al., 2010; Jadhav et al., 2019) 
and showing complex patterns, where the longer isoform has biallelic expression in human 
LCLs, while the shorter isoforms have paternal expression. In brains, the short isoforms were 
found to be monoallelic, the long isoform was biallelic and the intermediate isoforms showed 
incomplete silencing (Ben-David et al., 2014). Here, we found the intermediate isoforms showed 
neuron-specific imprinting, including their promoter regions. The long isoform showed imprinted 
expressions at some level in progenitors. These results indicate the imprinting can function not 
only to silence the expression of several genes in a region, but can also have more complex 
and specific effects leading to monoallelic expression of specific isoforms within specific cell-
types during neuronal development and differentiation. 
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Neuron-specific imprinted promoter of KANK1 (ANKRD15) gene 
The KANK family of proteins is known to regulate actin polymerization and cell migration 
(Kakinuma et al., 2009). A previous study showed that paternal inheritance of a deletion in the  
KANK1 (previously called ANKRD15) gene causes familial cerebral palsy (Lerer et al., 2005; 
Moreno-De-Luca et al., 2012). In lymphoblastoid cell lines (LCLs), the KANK1 gene is 
expressed in healthy individuals who carry a deletion on the maternal allele and a reference 
paternal allele, whereas in affected individuals who carry a paternal deletion and a reference 
maternal allele, the KANK1 gene is repressed. However, we do not know how the KANK1 gene 
affects brain development. The previous study was not able to determine whether imprinting is 
present within specific neural cell types or what regulatory elements exhibit evidence of 
imprinting. Here, we found that the promoter of KANK1 shows a neuron-specific imprinting 
pattern (Figure 4.5A and 4.5B). This imprinted promoter may lead to KANK1 paternal 
expression specifically in neurons, explaining in part a mechanism underlying the parent-of-
origin association to cerebral palsy. Identifying regulatory elements underlying parent-of-origin 
disorders could be useful for guiding gene therapy approaches (Wolter et al., 2020).   
4.3 Discussion 
Mutations at imprinted loci can lead to parent-of-origin dependent inheritance for 
neurodevelopmental disorders. In order to better explain the mechanism underlying parent-of-
origin disorders, imprinting must be quantified within relevant cell types and at biological levels 
beyond gene expression. By combining high-throughput sequencing data (RNA-seq and ATAC-
seq) with genotype data, we identified cell-type specific imprinted REs and imprinted genes in 
two major cell types during human neuronal differentiation. We identified well-known imprinted 
REs and genes in the PWS/AS region in neurons, indicating the robustness of our methods. We 
also identified cell-type specific imprinted REs and genes as new candidates for genomic 
imprinting. We found that imprinting does not necessarily lead to complete silencing of an entire 
gene, and instead can have complex cell-type and isoform-specific effects, as in neurons for 
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GET1 and ZNF331. Finally, using neuron-specific imprinted REs overlapping with the promoter 
of KANK1, we make a hypothesis for the mechanisms of parent-of-origin-dependent inheritance 
of familial cerebral palsy. 
Cell-type specific imprinted gene expression and chromatin accessibility shows dynamic 
changes of genomic imprinting during human neuronal differentiation. In addition to imprinted 
genes, we also identify the imprinted REs in neurons and progenitors, allowing us to explore the 
regulatory mechanisms of genomic imprinting. We found some genes only showed cell-type 
specific imprinted promoters but not imprinted expression, suggesting that the imprinted REs 
are established prior to imprinted expression. We also found the imprinted REs showed higher 
GC content and higher overlap with CpG island, suggesting the methylation of these REs is the 
mechanism of regulating imprinting chromatin accessibility.  
Here, we inferred genomic imprinting using allelic ratios. We separated genomic 
imprinting from allelic effects by using a threshold for the number of individuals with extreme 
allelic ratio. Though this technique has been used previously (Baran et al., 2015), future studies 
that directly measured parental genotypes will be useful to confirm the imprinted REs/genes 
identified here as well as identify additional REs/genes missed here.  Additional experimental 
validation is also necessary to detect the molecular mechanisms of genomic imprinting during 
human neuronal differentiation. For example, using iPSCs derived from individuals with parental 
genotypes can be used to confirm the genomic imprinting during neuronal differentiation. 
Genomic editing (deletion or modification) for imprinted REs can be used to study the regulation 
of imprinting. Finally, we envision that combining the cell-type specific genomic imprinting with 
parent-of-origin genome-wide association studies (GWASs) or parent-of-origin rare variants 





Figure 4.1. Imprinted regulatory elements and genes in progenitors and neurons. (A) Schematic cartoon 
of imprinting regulatory element and gene detection. (B) Imprinted regulatory elements in progenitors and 




Figure 4.2. Imprinted regulatory elements and genes at known imprinted loci. (A) ATAC-seq coverage plot 
(average normalized read counts) for PWS regions and SNPs inferred imprinted REs and genes. (B) 
Allelic reads plot for SNPs inferred neuron-specific imprinted REs at promoters of MAGEL2, NDN and 
SNRPN. (C) Allelic reads plot for SNPs inferred imprinted genes NDN and neuron-specific UBE3A. (D) 
ATAC-seq coverage plot (average normalized read counts) and allelic reads plot for SNPs inferred 
progenitor-specific imprinted gene MEG8. 
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Figure 4.3. GC content of imprinted REs and predicted TF motif enrichment in imprinted REs. (A) GC 
content of imprinted REs and non-imprinted REs in neurons and progenitors. (B) Overlap between CpG 
islands and  imprinted REs/non-imprinted REs in neurons and progenitors. (C) Enriched TF motifs in 
neuron imprinted REs and progenitor imprinted REs. 
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Figure 4.4. Imrpinted REs and genes indicating isoform-specific imprinting in neurons. (A) ATAC-seq 
coverage plot (average normalized read counts) around gene GET1. (B) Allelic reads plot for SNPs 
inferred neuron-specific imprinted REs at promoters of the GET1 isoform. (C) ATAC-seq coverage plot 
(average normalized read counts) around gene ZNF331. (D) Allelic reads plot for SNPs inferred neuron-




Figure 4.5. Neuron-specific imprinted promoter of KANK1 (ANKRD15) gene. (A) ATAC-seq coverage plot 
(average normalized read counts) at the promoter of  gene KANK1. (B) Allelic reads plot for the SNP 


















Cell culture of primary human neural progenitor cells (phNPCs) 
We cultured and differentiated the phNPCs into neurons following the same methods in 
our previous work (D. Liang et al., 2020; Stein et al., 2014).  
ATAC-seq and RNA-seq library preparation for human neural progenitors and neurons 
ATAC-seq libraries were prepared immediately following cellular dissociation using our 
previous methods (Buenrostro et al., 2015; D. Liang et al., 2020). All libraries were sequenced 
on an Illumina HiSeq2500 or MiSeq machine using 50 bp paired-end sequencing. RNA-seq 
libraries were prepared as previously described (Aygün et al., 2020) and were sequenced on a 
NovaSeq S2 flowcell using 150 bp paired-end sequencing. 
ATAC-seq, RNA-seq, and genotype data pre-processing 
Raw ATAC-seq and RNA-seq data were quality controlled and aligned to the human 
genome (GRCh38/hg38) using WASP to prevent mapping bias as previously described (Aygün 
et al., 2020; D. Liang et al., 2020). Genotype data were preprocessed and imputed as 
previously described (D. Liang et al., 2020). 
Allele-specific chromatin accessibility and gene expression 
We used GATK tools to extract allele-specific read counts for every bi-allelic SNP (in 
accessible peaks or expression regions). We first filtered for SNPs within each donor that had 
sufficient read depth by retaining SNPs with total counts greater than or equal to 10 for neuron 
and progenitor samples, separately. Then to calculate allele-specific chromatin accessibility and 
gene expression, we retained those SNPs with average read counts for all heterozygous donors 
greater than or equal to 15. Finally, we retained only those SNPs that meet these previous 
thresholds for at least 5 heterozygous donors. 
Estimation of dispersions and identify the imprinted chromatin accessibility and gene expression 
We estimated the dispersion using a likelihood ratio test based on the beta-binomial 
distribution of the allelic ratio (# reads from the reference allele/# reads from the reference allele 
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and alternative allele) at each SNPs. The allelic ratio can be modelled by binomial distribution 
with the probability of expressing the parental-specific allele modelled by beta distribution. In the 
combined beta-binomial distribution, the null hypothesis is an equal probability of getting reads 
from the two alleles. And using the likelihood-log ratio, we can measure the significance for the 
dispersion of allelic ratio distribution of the heterozygous SNPs. To identify the imprinted 
chromatin accessibility and gene expression, we identify the SNPs in imprinted accessible or 
expression regions using the following three conditions: 1) SNPs have at least 2 donors have an 
allelic ratio greater than or equals to 0.8; 2) SNPs have at least 2 donors have an allelic ratio 
less than or equals to 0.2; and 3) SNPs have significant over-dispersion (Benjamini-Hochberg 
FDR < 0.05) of the allelic ratio. 
TFBS enrichment analysis 
Potential transcription factor binding sites were called in the human genome using 
TFBSTools from the JASPAR2016 core database as previously (D. Liang et al., 2020). We 
calculated the enrichment of TFBS in Neuron/Progenitor imprinted Res using the binomial test 
(McLean et al., 2010). First, we found all TFBSs for a given TF in accessible regions (n) and 
calculated the fraction of base pairs of the motif compared to the overall base pairs of 
accessible peaks. Then, we counted the number of TFBSs for this TF (k). The final step was to 
calculate P=Prbinom(x>=k|n,p) using the binomial test to get the significance of the enrichment. 
We further filtered the enrichment results by differential expression from the same set of cells, 
and only kept the TFs with cell-type specific significantly enriched in imprinted Res and 










CHAPTER 5 DISCUSSION 
 
In my graduate work, I identified transcription factors regulating human neurogenesis 
based on human fetal brain chromatin accessibility in Chapter 2, mapped genetic effects on 
chromatin accessibility and predicted regulatory mechanisms underlying brain-related traits in 
two major cell types during human neuronal differentiation in Chapter 3, and identified putatively 
imprinted genes and imprinted regulatory elements in these two cell types in Chapter 4. These 
studies have focused on the goal of identifying causal variants and underlying molecular 
mechanisms impacting human brain development and risk for neuropsychiatric disorders. The 
results of my work have led to different insights into the challenges and directions for future 
studies. 
5.1 Understanding regulatory mechanisms of non-coding GWAS loci   
Combining cell-type specific caQTLs with brain related GWAS data, we identified 87 
colocalizations between caQTLs and neuropsychiatric risk loci/brain structure related loci. We 
identified the regulatory elements that are involved in the regulation underlying these loci and 
predicted TFs binding to the regulatory elements. caQTLs provided more information than 
eQTLs to locate the causal variants by identifying variants in regulatory elements. However, it is 
hard to predict the downstream regulated genes without eQTLs. Combining eQTLs, caQTLs 
and GWAS data, we identified how the causal genetic variants affect TFs binding, chromatin 
accessibility of the regulatory elements and expression of the downstream genes. Especially, 
we found the regulatory mechanisms are different from the prediction only based on GWAS 
data. For example, the GWAS studies predicted LRFN5 as the gene involved in MMD because 
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the index SNP rs1950829 is nearby LRFN5 gene (in Chapter 3) (Wray et al., 2018), 
however, we found the lncRNA AL121821.1 is the downstream regulated gene underlying the 
MDD GWAS locus specifically in progenitors. Another example is for schizophrenia GWAS, the 
index SNP rs7191183 is in the intron of the GRIN2A gene (Consortium & Schizophrenia 
Working Group of the Psychiatric Genomics Consortium, 2014), so GRIN2A is predicted as the 
gene involved in changing the risk for schizophrenia. In Chapter 3, we identified colocalization 
between neuron-specific caQTLs and schizophrenia GWAS at this locus, but we did not find 
eQTLs colocalized with caQTLs or schizophrenia GWAS at this loci in progenitors or neurons, 
indicating GRIN2A is not involved in regulating of the risk for schizophrenia during neuronal 
development and differentiation. These new findings provide further understanding of 
mechanisms underlying non-coding GWAS loci for neuropsychiatric disorders.  
Furthermore, we are able to predict how TF binding affects chromatin accessibility of the 
regulatory elements using caQTLs and the position weight matrix of the TF. We find the binding 
of activators are associated with increased chromatin accessibility, yet the binding of repressors 
are associated with decreased chromatin accessibility. These results indicate different 
regulatory mechanisms of activators and repressors: the binding of repressors creates a more 
condensed chromatin structure around the binding sites, resulting in the inactivity of the 
regulatory elements, however, the binding of activators creates a more accessible chromatin 
structure around the binding sites, resulting in the activity of the regulatory elements. In future 
studies, different binding patterns for repressors and activators need to be studied. One 
computational approach is to perform digital genomic footprints using ATAC-seq data (Galas & 
Schmitz, 1978; Piper et al., 2013; Pique-Regi et al., 2011; Raj et al., 2015). For the experimental 
approaches, high-resolution or single-molecule imaging approaches are promising to study how 
a certain TF binding effects on chromatin accessibility in living cells (Z. Liu & Tjian, 2018; Suter, 
2020). However, how to perform the experimental approaches in a high throughput way is still a 
question that needs to be addressed. In addition to progenitors and neurons, we also need to 
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study the effects of TF binding on chromatin accessibility in other different cell types to confirm 
the conclusion we draw. 
Finally, we are able to infer the imprinted regulatory elements and genes in progenitors 
and neurons using chromatin accessibility/gene expression data and genotype data. Even 
though, previous studies identified imprinted genes in different tissues using the similar methods 
(Babak et al., 2015; Baran et al., 2015; Santoni et al., 2017), to our knowledge, this is the first 
time to study imprinted regulatory elements and genes in these two cell types. Especially, 
imprinted regulatory elements are poorly understood in most tissues or cell types. We found 
some previously unknown genes and regulatory elements as the candidates for studying 
genomic imprinting. In further studies, combining imprinted regulatory elements and genes with 
parent-of-origin genetic association studies, may allow better understanding of mechanisms 
underlying neurodevelopmental disorders. And the experiment validations in the iPSCs with 
known genotype data from parents are still necessary to confirm inferred imprinted regulatory 
elements/genes and their functions during human neuronal differentiation. 
5.2 caQTLs vs eQTLs 
QTLs for different molecular traits are one of the most useful methods to study the 
function of genetic variants, because these studies directly link genetic variants to downstream 
molecular phenotypes, such as gene expression and chromatin accessibility: e(s)QTLs link 
regulatory variants to specific genes, and caQTLs provide strong evidence for the causal 
variants within regulatory elements. In Chapter 3, the results showed caQTLs had higher effect 
sizes than eQTLs, indicating that we may identify more common variants involved in genetic 
regulation than eQTLs given the same sample sizes using caQTLs. But for now, this conclusion 
is only supported in certain cell types because there are limited data resources to perform this 
comparison across different cell types. In the future, it is necessary to validate the conclusion in 
other cell types by performing eQTLs and caQTLs in the same cell types. Based on the higher 
effect sizes of caQTLs and the ability to locate the causal variation in the regulatory elements, I 
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think caQTLs could be a better choice for discovering more regulatory variants compared to 
eQTLs. 
As with GWAS studies, QTLs also have limitations. Identifying the causal variants for an 
association (fine-mapping) is still very difficult, especially for e(s)QTLs. caQTLs improve the 
ability to locate the causal genetic variants by identifying genetic variants within and affecting 
non-coding functional  regulatory elements. However, we found 20% of caSNPs are not in their 
regulated elements (Chapter 3), indicating other regulatory mechanisms explaining chromatin 
accessibility, such as genetic variants in regulatory elements regulate distal regulatory elements 
via chromatin-chromatin interactions. Moreover, the final goal of fine-mapping is not only to 
identify causal variants but also to understand the underlying causal mechanisms leading to 
changes in complex traits. To do so, we still need to overcome a couple of difficulties. First, 
regulatory variants can act in many different ways in addition to the well-known mechanisms, 
such as affecting TF binding sites with downstream gene expression. For example, regulatory 
variants can also affect expression of non-coding RNAs, DNA methylation, and chromatin-
chromatin interactions, which result in even more complex regulatory decades to affect complex 
traits (Cavalli et al., 2019; Hrdlickova et al., 2014; Huishan Wang et al., 2018). To predict the 
diverse and complex molecular mechanisms require 1) detection of these molecular traits in 
certain cell types or cell states and 2) a robust statistical model to build the causal pathway. 
Second, regulatory variants can affect one or more genes or other molecular traits. So instead 
of pathways with only one gene/regulatory element at each biological level, it is more likely that 
regulatory variants can make changes in the networks at each biological level. For example, 
one genetic variant affects one TF binding, but causes expression changes in three genes, and 
the three genes cause changes in their downstream regulation, which forms changes in a 
regulation network. There could be multiple regulatory networks involved in complex traits. 
Some networks are core networks that have higher effects on diseases and some networks 
affecting the core networks have small effects on diseases. So how to appropriately quantify the 
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effects of regulatory pathways or networks, is still a question to be addressed. Finally, 
experimental validations for predicted mechanisms underlying causal variants is also 
challenging, because we need to use a series of experiments to detect changes for multiple 
molecular traits, like chromatin accessibility, TF binding and gene expression. In addition to 
detect the activity of regulatory elements using luciferase assay, allele-specific ChIP-qPCR 
(Bailey et al., 2015) can be used to detect different TF binding affinity between alleles at a 
certain SNP. Then the changes of downstream gene expression can be detected by qPCR with 
over-expression of the TF. It is still hard to detect all the molecular changes at the same time, 
but combining different experiments could be a way to validate the predicted regulatory 
mechanisms. 
Additionally, genetic regulation is cell-type and context specific, and in Chapter 3 the 
results showed caQTLs have a higher cell-type specificity than eQTLs in neurons and neuronal 
progenitors. So the previous studies (GTEx Consortium, 2020; GTEx Consortium et al., 2017) 
showed a high proportion of sharing eQTLs across different tissues may be caused by a mixing 
of multiple cell types in bulk tissue. This may also be the reason for the limited colocalized loci 
found between QTLs and GWAS (Donovan et al., 2020; GTEx Consortium, 2020), because only 
a certain cell type or multiple cell types are involved in the complex traits. To understand more 
GWAS loci, we may need more cell type specific QTLs because there may be multiple cell types 
involved in the changes of complex traits. It is important to bring all available data together 
across different cell types to identify the causal variants and understand underlying 
mechanisms. 
5.3 Cell-type specific QTLs 
There are a couple of ways to detect genetic effects in different cell types by using single 
cell sequencing approaches. A direct way is to perform the single cell sequencing in tissues 
from multiple donors. With the genotype data of the donors, QTLs for gene expression and 
chromatin accessibility can be detected in major cell types from the tissues. Another advantage 
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of single cell sequencing approaches is to identify new cell types (See et al., 2017). Even 
though there are still limitations for this method, more and more efforts have been made to solve 
them. First, single cell sequencing data have lower signal-to-noise ratio (Eraslan et al., 2019) 
due to the low RNA capture rate in certain cell types, which increases the difficulties of cell-type 
specific QTL detection. There are some existing methods existing to solve the problems (M. 
Huang et al., 2018; Ronen & Akalin, 2018; van Dijk et al., 2017), which use the correlation 
structure of single-cell gene expression data to infer gene expression values by leveraging the 
similarities between cells and/or genes. These statistical methods to control the noise of single 
cell sequencing data will improve the power of cell-type specific QTL detection. Second, single 
cell sequencing and genotyping are relatively expensive now, but are decreasing in cost. Using 
single-cell sequencing in a large scale of individuals is a great way to perform QTL mapping for 
molecular traits in different cell types. The other way to detect cell-type specific QTLs is to use 
existing bulk high-throughput sequencing data, such as RNA-seq data from GTEx dataset. Cell-
type specific content of bulk tissue can be estimated through deconvolution using single cell 
sequencing data from tissues (Donovan et al., 2020), after which cell-type specific QTLs can be 
mapped by detecting if the genetic variants and cell type specificity are significantly associated 
with molecular traits. Both of these methods can be used in the future to explore cell-type 
specific QTLs in other cell types, before we can get single cell sequencing data from a large 
scale of individuals, using existing bulk high-throughput sequencing data is an efficient way to 
map cell-type specific QTLs. 
A recent method called Census-seq (Mitchell et al., 2020) gives a new ability to detect 
context specific QTLs in cell lines from different donors. With the known genotype data, cells 
from multiple donors can be pooled and cultured together, called “villages”. The specific cell 
contexts can be induced by small molecules or genomic editing. First, derived villages were 
created by sorting or selection enriches cells with phenotypes of interest. Then, genomic DNA is 
extracted from each village and sequenced. Finally, Census-seq analysis measures each 
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donor’s contribution to the village’s genomic DNA, and the relative number of cells from each 
donor in each village. A donor’s change in representation between such derived villages is a 
quantitative phenotype that can then be analyzed genetically or in relationship to other 
variables, such as donor age or health status. Pooling will reduce the technical factors in cell 
culture and improve the power. This method will also decrease the cost for large scale iPSC 
based studies, because pooling cells can reduce the amount of work for cell culture and reduce 
the price for sequencing. Compared to sequencing one dish of cells from every donor in a 
population-scale like we did in Chapter 3, Census-seq can largely reduce the price by 
sequencing pooled cell lines in one dish for about 10 donors. However, Census-seq focuses on 
one phenotype (that can be quantified by sorting) at a time, QTLs can be used to measure 
thousands of molecular traits at a time. So for a certain phenotype that can be sorted, Census-
seq can be used to perform genome-wide association studies with a lower price. 
5.4 Colocalization and mediation 
In my work, the aim of colocalization across caQTLs, eQTLs and GWAS loci is to find 
the causal variants underlying risk loci. Even though more and more statistical methods have 
been invented to identify colocalized loci, there are still some challenges in colocalization. 
Although different LD structures can benefit colocalization by narrowing down the high LD 
regions, limited colocalization methods, such as eCAVIAR (Hormozdiari et al., 2016), can use 
different LD structures from QTLs and GWAS to identify causal variants. And the situation will 
be complex when there are more than one causal variants in the same locus, which requires a 
more complicated statistical model to identify the colocalized loci. A direct problem will be a 
heavy computational burden, for example, it takes 100 more hours to identify 3 possible causal 
variants in one locus using eCAVIAR, which is not really practical. In Chapter 3, we used 
reciprocal conditional analysis to confirm the colocalization between caQTLs and GWAS data. 
Because caQTLs provided strong evidence for causal variants in the regulatory elements, which 
 102 
improved the efficiency of colocalization. In the future studies, it will be better to include caQTLs 
in the statistical models for colocalization analysis between QTLs and GWAS. 
In addition to colocalization, the mediation analysis is also important to identify the 
regulatory pathway, because it can confirm the regulatory relationship and regulatory direction 
between chromatin accessibility and gene expression. The aim of mediation analysis is to detect 
whether a relationship between two variables (genetic variants and gene expression in this 
case) can be explained by a mediating variable (chromatin accessibility of regulatory elements) 
(MacKinnon et al., 2007). Several statistical methods based on regression modules were 
developed to discover the mediating genes for disease risk loci (Hou et al., 2021; Lutz & 
Hokanson, 2015; Peng et al., 2020). In the future studies, using similar statistical approaches, 
the mediating regulatory elements can be confirmed for eQTLs using the caQTLs and eQTLs in 
progenitors and neurons. And it is also interesting to identify the mediating regulatory elements 
and genes for neuropsychiatric risk loci using the cell-type specific eQTLs and caQTLs for 
discovering cell-type specific regulatory pathways involved in neuropsychiatric disorders. 
5.5 Model systems for experimental validation  
It is necessary to perform experiments in cell/tissue models to experimentally validate 
complex regulatory mechanisms. Cell model systems like hNPCs or iPSCs provide a way to get 
specific cell types/states and allow multiple molecular assays to be performed, such as 
CRISPR-Cas9 can be used to engineer the genome in the cells. In Chapter 3, we used viruses 
to label neurons so that we can separate neurons from other cell types, and performed ATAC-
seq/RNA-seq on the cells. Cell model systems can be used to detect molecular and cellular 
changes, such as enhancer activity (luciferase assays), gene expression level (qPCR) and cell 
growth (imaging analysis). A more high-throughput method is Massively Parallel Reporter 
Assays (MPRA), which combines luciferase reporter assays and massively parallel sequencing 
to test tens of thousands of different transcriptional activities of DNA elements at the same time 
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in cells (Kheradpour et al., 2013; Melnikov et al., 2012). So a cell model system can be the 
easiest way to perform experiments to validate the hypothesis based on QTL/GWAS studies. 
iPSC-derived organoids are model systems of human brain development, which can be 
used to study molecular changes in different cell types (combining single-cell approaches) and 
brain regions during development (Kanton et al., 2019; C.-T. Lee et al., 2017; Marton & Pașca, 
2020; Sawada et al., 2020; Tanaka et al., 2020). In addition to having multiple cell types, brain 
organoids also keep the “inside-out” pattern (the earliest produced neurons migrate to the 
deepest cortical layers. Subsequently migrating neurons migrate to successively more 
superficial layers creating an inside out order of migration) of developing brains, providing 
models at tissue level with different genetic backgrounds. And genetically engineered iPSCs or 
iPSCs from patients can be used to study how genetic variants affect cell types, brain structures 
and neural circuits during brain development at tissue levels. Even though a better protocol of 
brain organoids production is still necessary to improve the replicates of brain organoids culture, 
organoids are the best model to study how genetic variants affect human brain development for 
now due to the scarcity and inoperability of fetal tissues. 
Mouse models usually are used to study complex behaviors related to neuropsychiatric 
disorders. However, many regulatory mechanisms are human-specific, which brings difficulty in 
using mouse models. Using humanized mouse models, for example replacing a mouse 
enhancer with a human-specific enhancer, is a good way to study how genetic regulation affects 
brain development in vitro and complex behavior which can not be obtained from the cell based 
model systems. 
5.6 Summary 
GWAS have identified thousands of genetic loci associated with neuropsychiatric 
disorders, but the understanding of underlying molecular mechanisms for the associations are 
still poor. The growing genomic data for different cell types/cell states/tissues bring opportunities 
to decipher the function of non-coding genetic variation. In my thesis, we mapped cell-type 
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specific caQTLs in neuronal progenitors and neurons. By comparing caQTLs and eQTLs, we 
found caQTLs had higher cell-type specificity than eQTLs in the two cell types, indicating cell-
type specific genetic regulations during human brain development. With the strong evidence for 
causal variants from caQTLs, we predicted the molecular mechanisms underlying disease risk 
loci by colocalization among caQTLs, eQTLs and GWAS data. But there are many important 
questions to be answered. How many causal variants are there in a locus and in a complex 
trait? How can we quantify the effects of genetic regulatory networks leading to differences in 
complex traits? How can the data from large-scale sequencing and genotyping can be used to 
develop therapies for neuropsychiatric disorders? I aim to explore these questions using new 
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